Kamagra online without prescriptionSALT LAKE kamagra online without prescription CITY, http://taettag.pressesite.dk/how-do-you-get-kamagra/ Nov. 24, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", kamagra online without prescription Nasdaq. HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Patrick Nelli, President, Bryan Hunt, CFO and Adam Brown, SVP of Investor Relations and FP&A, will participate in the following upcoming investor conferences. Piper Sandler 32nd Annual Virtual Healthcare Conference on Wednesday, kamagra online without prescription December 2, 2020, which will include a fireside chat presentation. An audio-only recording will be available at https://ir.healthcatalyst.com/investor-relations.Evercore ISI HealthCONx Conference on Thursday, December 3, 2020, which will include a fireside chat presentation at 4:20 p.m. EST.Guggenheim Digital Health Virtual Conference which will include a kamagra online without prescription fireside chat presentation on Tuesday, December 8, 2020 at 3:15 p.m. EST, as well as one-on-one meetings on Wednesday, December 9, 2020.About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platformâÂÂpowered by data from more than 100 million patient records and encompassing trillions of factsâÂÂas well as its analytics software and professional services expertise to make data-informed decisions kamagra online without prescription and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed. Health Catalyst Investor Relations Contact kamagra online without prescription. Adam BrownSenior Vice President, Investor Relations and FP&A+1 (855)-309-6800ir@healthcatalyst.com Health Catalyst Media Contact. Kristen BerryVice President, Public Relations+1 (617) 234-4123+1 (774) 573-0455 (m)kberry@we-worldwide.comSALT LAKE kamagra online without prescription CITY, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", kamagra online without prescription Nasdaq. HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Patrick Nelli, President, Bryan Hunt, CFO and Adam Brown, SVP of Investor Relations and FP&A, will participate in the following upcoming investor conferences:Piper Sandler 32nd Annual Virtual Healthcare Conference on Wednesday, December 2, 2020, which will include a fireside chat presentation. An audio-only recording kamagra online without prescription will be available at https://ir.healthcatalyst.com/investor-relations. Evercore ISI HealthCONx Conference on Thursday, December 3, 2020, which will include a fireside chat presentation at 4:20 p.m. EST. Guggenheim Digital Health Virtual Conference which will include a fireside chat presentation on Tuesday, December 8, 2020 at 3:15 p.m. EST, as well as one-on-one meetings on Wednesday, December 9, 2020.About Health CatalystHealth Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platformâÂÂpowered by data from more than 100 million patient records and encompassing trillions of factsâÂÂas well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.Health Catalyst Investor Relations Contact:Adam BrownSenior Vice President, Investor Relations and FP&A+1 (855)-309-6800ir@healthcatalyst.comHealth Catalyst Media Contact:Kristen BerryVice President, Public Relations+1 (617) 234-4123+1 (774) 573-0455 (m)kberry@we-worldwide.com Source. Health Catalyst, Inc.. Kamagra oral jelly sildenafil
1 http://keim-farben.de/buy-ventolin-online-with-free-samples kamagra oral jelly sildenafil. Access CMS' website address at website address at https://www.cms.gov/âÂÂRegulations-and-Guidance/âÂÂLegislation/âÂÂPaperworkReductionActof1995/âÂÂPRA-Listing.html. Start Further Info William N. Parham at kamagra oral jelly sildenafil (410) 786-4669. End Further Info End Preamble Start Supplemental Information Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection's supporting statement and associated materials (see ADDRESSES). CMS-10280âÂÂHome Health Change of Care Notice CMS-1557âÂÂSurvey Report Form for Clinical Laboratory Improvement Amendments (CLIA) kamagra oral jelly sildenafil and Supporting Regulations CMS-3070G-IâÂÂICF/IID Survey Report Form and Supporting Regulations Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term âÂÂcollection of informationâ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and kamagra oral jelly sildenafil includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collection kamagra oral jelly sildenafil 1. Type of Information Collection Request. Extension of a currently approved collection. Title of the kamagra oral jelly sildenafil Information Collection. Home Health Change of Care Notice. Use. The purpose of the Home Health kamagra oral jelly sildenafil Change of Care Notice (HHCCN) is to notify original Medicare beneficiaries receiving home health care benefits of plan of care changes. Home health agencies (HHAs) are required to provide written notice to Original Medicare beneficiaries under various circumstances involving the reduction or termination of items and/or services consistent with Home Health Agencies Conditions of Participation (COPs). The home health COP requirements are set forth in çâÂÂ1891[42 U.S.C. 1395bbb] of the Social kamagra oral jelly sildenafil Security Act (the Act). The implementing regulations under 42 CFR 484.10(c) specify that Medicare patients receiving HHA services have rights. The patient has the right to be informed, in advance about the care to be furnished, and of any changes in the care to be furnished. The HHA must advise the kamagra oral jelly sildenafil patient in advance of the disciplines that will furnish care, and the frequency of visits proposed to be furnished. The HHA must advise the patient in advance of any change in the plan of care before the change is made.â Notification is required for covered and non-covered services listed in the plan of care (POC). The beneficiary will use the information provided to decide whether or not to pursue alternative options to continue receiving the care noted on the HHCCN. Form Number kamagra oral jelly sildenafil. CMS-10280 (OMB control number. 0938-1196). Frequency. Yearly. Affected Public. Private Sector (Business or other for-profits, Not-for-Profit Institutions). Number of Respondents. 11,157. Total Annual Responses. 12,385,108. Total Annual Hours. 824,848. (For policy questions regarding this collection contact Jennifer McCormick at 410-786-2852.) 2. Type of Information Collection Request. Extension of a currently approved collection. Title of Information Collection. Survey Report Form for Clinical Laboratory Improvement Amendments (CLIA) and Supporting Regulations. Use. The form is used to report surveyor findings during a CLIA survey. For each type of survey conducted (i.e., initial certification, recertification, validation, complaint, addition/deletion of specialty/subspecialty, transfusion fatality investigation, or revisit inspections) the Survey Report Form incorporates the requirements specified in the CLIA regulations. Form Number. CMS-1557 (OMB control number. 0938-0544). Frequency. Biennially. Affected Public. Private sector (Business or other for-profit and Not-for-profit institutions, State, Local or Tribal Governments and Federal Government). Number of Respondents. 15,975. Total Start Printed Page 46855Annual Responses. 7,988. Total Annual Hours. 3,994. (For policy questions regarding this collection contact Kathleen Todd at 410-786-3385). 3. Type of Information Collection Request. Revision of a currently approved collection. Title of Information Collection. ICF/IID Survey Report Form and Supporting Regulations. Use. The information collected with forms 3070G, CMS-3070H and CMS-3070I is used by the surveyors from the State Survey Agencies (SAs) to determine the level of compliance with the ICF/IID Conditions of Participation (CoPs) necessary to participate in the Medicare/Medicaid program and to report any non-compliance with the ICF/IID CoPs to the Federal government. These forms summarize the survey team characteristics, facility characteristics, client population, and the special needs of clients. These forms are used in conjunction with the CMS regulation text and additional surveyor aids such as the CMS interpretive guidelines and probes. The CMS-3070G-I forms serves as coding worksheets, designed to facilitate data entry and retrieval into the Automated Survey Processing Environment Suite (ASPEN) in the State and at the CMS regional offices. Form Number. CMS-3070G-I (OMB control number. 0938-0062). Frequency. ReportingâÂÂYearly. Affected Public. Business or other for-profits and Not-for-profit institutions. Number of Respondents. 5,758. Total Annual Responses. 5,758. Total Annual Hours. 17,274. (For policy questions regarding this collection contact Caroline Gallaher at 410-786-8705.) Start Signature Dated. August 17, 2021. William N. Parham, III Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. End Signature End Supplemental Information [FR Doc. 2021-17908 Filed 8-19-21. 8:45 am]BILLING CODE 4120-01-PStart Preamble Centers for Medicare &. Medicaid Services, Health and Human Services (HHS). Notice. The Centers for Medicare &. Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our Start Printed Page 42842burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Comments must be received by October 4, 2021. When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways. 1. Electronically. You may send your comments electronically to http://www.regulations.gov. Follow the instructions for âÂÂComment or Submissionâ or âÂÂMore Search Optionsâ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address. CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention. Document Identifier/OMB Control Number. __, Room C4-26-05, 7500 Security Boulevard, Baltimore, Maryland 21244-1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following. 1. Access CMS' website address at website address at https://www.cms.gov/âÂÂRegulations-and-Guidance/âÂÂLegislation/âÂÂPaperworkReductionActof1995/âÂÂPRA-Listing.html. Start Further Info William N. Parham at (410) 786-4669. End Further Info End Preamble Start Supplemental Information Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection's supporting statement and associated materials (see ADDRESSES). CMS-10148âÂÂHIPAA Administrative Simplification (Non-Privacy/Security) Complaint Form CMS-10784âÂÂThe Home Health Care CAHPSî Survey (HHCAHPS) Mode Experiment Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term âÂÂcollection of informationâ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collection 1. Type of Information Collection Request. Extension of a currently approved collection. Title of Information Collection. HIPAA Administrative Simplification (Non-Privacy/Security) Complaint Form. Use. The Secretary of Health and Human Services (HHS), hereafter known as âÂÂThe Secretary,â codified 45 CFR parts 160 and 164 Administrative Simplification provisions that apply to the enforcement of the Health Insurance Portability and Accountability Act of 1996 Public Law 104-191 (HIPAA). The provisions address rules relating to the investigation of non-compliance of the HIPAA Administrative Simplification code sets, unique identifiers, operating rules, and transactions. 45 CFR 160.306, Complaints to the Secretary, provides for investigations of covered entities by the Secretary. Further, it outlines the procedures and requirements for filing a complaint against a covered entity. Anyone can file a complaint if he or she suspects a potential violation. Persons believing that a covered entity is not utilizing the adopted Administrative Simplification provisions of HIPAA are voluntarily requested to file a complaint with CMS via the Administrative Simplification Enforcement and Testing Tool (ASETT) online system, by mail, or by sending an email to the HIPAA mailbox at hipaacomplaint@cms.hhs.gov. Information provided on the standard form will be used during the investigation process to validate non-compliance of HIPAA Administrative Simplification provisions. This standard form collects identifying and contact information of the complainant, as well as the identifying and contact information of the filed against entity (FAE). This information enables CMS to respond to the complainant and gather more information if necessary, and to contact the FAE to discuss the complaint and CMS' findings. Form Number. CMS-10148 (OMB control number. 0938-0948). Frequency. Occasionally. To obtain copies of Buy ventolin online with free samples a supporting statement and any related forms for the kamagra online without prescription proposed collection(s) summarized in this notice, you may make your request using one of following. 1. Access CMS' website address at website address at https://www.cms.gov/âÂÂRegulations-and-Guidance/âÂÂLegislation/âÂÂPaperworkReductionActof1995/âÂÂPRA-Listing.html. Start kamagra online without prescription Further Info William N. Parham at (410) 786-4669. End Further Info End Preamble Start Supplemental Information Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection's supporting statement and associated materials (see ADDRESSES) kamagra online without prescription. CMS-10280âÂÂHome Health Change of Care Notice CMS-1557âÂÂSurvey Report Form for Clinical Laboratory Improvement Amendments (CLIA) and Supporting Regulations CMS-3070G-IâÂÂICF/IID Survey Report Form and Supporting Regulations Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term âÂÂcollection of kamagra online without prescription informationâ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is kamagra online without prescription publishing this notice. Information Collection 1. Type of Information Collection Request. Extension of kamagra online without prescription a currently approved collection. Title of the Information Collection. Home Health Change of Care Notice. Use. The purpose of the Home Health Change of Care Notice (HHCCN) is to notify original Medicare beneficiaries receiving home health care benefits of plan of care changes. Home health agencies (HHAs) are required to provide written notice to Original Medicare beneficiaries under various circumstances involving the reduction or termination of items and/or services consistent with Home Health Agencies Conditions of Participation (COPs). The home health COP requirements are set forth in çâÂÂ1891[42 U.S.C. 1395bbb] of the Social Security Act (the Act). The implementing regulations under 42 CFR 484.10(c) specify that Medicare patients receiving HHA services have rights. The patient has the right to be informed, in advance about the care to be furnished, and of any changes in the care to be furnished. The HHA must advise the patient in advance of the disciplines that will furnish care, and the frequency of visits proposed to be furnished. The HHA must advise the patient in advance of any change in the plan of care before the change is made.â Notification is required for covered and non-covered services listed in the plan of care (POC). The beneficiary will use the information provided to decide whether or not to pursue alternative options to continue receiving the care noted on the HHCCN. Form Number. CMS-10280 (OMB control number. 0938-1196). Frequency. Yearly. Affected Public. Private Sector (Business or other for-profits, Not-for-Profit Institutions). Number of Respondents. 11,157. Total Annual Responses. 12,385,108. Total Annual Hours. 824,848. (For policy questions regarding this collection contact Jennifer McCormick at 410-786-2852.) 2. Type of Information Collection Request. Extension of a currently approved collection. Title of Information Collection. Survey Report Form for Clinical Laboratory Improvement Amendments (CLIA) and Supporting Regulations. Use. The form is used to report surveyor findings during a CLIA survey. For each type of survey conducted (i.e., initial certification, recertification, validation, complaint, addition/deletion of specialty/subspecialty, transfusion fatality investigation, or revisit inspections) the Survey Report Form incorporates the requirements specified in the CLIA regulations. Form Number. CMS-1557 (OMB control number. 0938-0544). Frequency. Biennially. Affected Public. Private sector (Business or other for-profit and Not-for-profit institutions, State, Local or Tribal Governments and Federal Government). Number of Respondents. 15,975. Total Start Printed Page 46855Annual Responses. 7,988. Total Annual Hours. 3,994. (For policy questions regarding this collection contact Kathleen Todd at 410-786-3385). 3. Type of Information Collection Request. Revision of a currently approved collection. Title of Information Collection. ICF/IID Survey Report Form and Supporting Regulations. Use. The information collected with forms 3070G, CMS-3070H and CMS-3070I is used by the surveyors from the State Survey Agencies (SAs) to determine the level of compliance with the ICF/IID Conditions of Participation (CoPs) necessary to participate in the Medicare/Medicaid program and to report any non-compliance with the ICF/IID CoPs to the Federal government. These forms summarize the survey team characteristics, facility characteristics, client population, and the special needs of clients. These forms are used in conjunction with the CMS regulation text and additional surveyor aids such as the CMS interpretive guidelines and probes. The CMS-3070G-I forms serves as coding worksheets, designed to facilitate data entry and retrieval into the Automated Survey Processing Environment Suite (ASPEN) in the State and at the CMS regional offices. Form Number. CMS-3070G-I (OMB control number. 0938-0062). Frequency. ReportingâÂÂYearly. Affected Public. Business or other for-profits and Not-for-profit institutions. Number of Respondents. 5,758. Total Annual Responses. 5,758. Total Annual Hours. 17,274. (For policy questions regarding this collection contact Caroline Gallaher at 410-786-8705.) Start Signature Dated. August 17, 2021. William N. Parham, III Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. End Signature End Supplemental Information [FR Doc. 2021-17908 Filed 8-19-21. 8:45 am]BILLING CODE 4120-01-PStart Preamble Centers for Medicare &. Medicaid Services, Health and Human Services (HHS). Notice. The Centers for Medicare &. Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our Start Printed Page 42842burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Comments must be received by October 4, 2021. When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways. 1. Electronically. You may send your comments electronically to http://www.regulations.gov. Follow the instructions for âÂÂComment or Submissionâ or âÂÂMore Search Optionsâ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address. CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention. Document Identifier/OMB Control Number. __, Room C4-26-05, 7500 Security Boulevard, Baltimore, Maryland 21244-1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following. 1. Access CMS' website address at website address at https://www.cms.gov/âÂÂRegulations-and-Guidance/âÂÂLegislation/âÂÂPaperworkReductionActof1995/âÂÂPRA-Listing.html. Start Further Info William N. Parham at (410) 786-4669. End Further Info End Preamble Start Supplemental Information Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection's supporting statement and associated materials (see ADDRESSES). CMS-10148âÂÂHIPAA Administrative Simplification (Non-Privacy/Security) Complaint Form CMS-10784âÂÂThe Home Health Care CAHPSî Survey (HHCAHPS) Mode Experiment Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term âÂÂcollection of informationâ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collection 1. Type of Information Collection Request. Extension of a currently approved collection. Title of Information Collection. HIPAA Administrative Simplification (Non-Privacy/Security) Complaint Form. Use. The Secretary of Health and Human Services (HHS), hereafter known as âÂÂThe Secretary,â codified 45 CFR parts 160 and 164 Administrative Simplification provisions that apply to the enforcement of the Health Insurance Portability and Accountability Act of 1996 Public Law 104-191 (HIPAA). The provisions address rules relating to the investigation of non-compliance of the HIPAA Administrative Simplification code sets, unique identifiers, operating rules, and transactions. 45 CFR 160.306, Complaints to the Secretary, provides for investigations of covered entities by the Secretary. Further, it outlines the procedures and requirements for filing a complaint against a covered entity. Anyone can file a complaint if he or she suspects a potential violation. Persons believing that a covered entity is not utilizing the adopted Administrative Simplification provisions of HIPAA are voluntarily requested to file a complaint with CMS via the Administrative Simplification Enforcement and Testing Tool (ASETT) online system, by mail, or by sending an email to the HIPAA mailbox at hipaacomplaint@cms.hhs.gov. Information provided on the standard form will be used during the investigation process to validate non-compliance of HIPAA Administrative Simplification provisions. This standard form collects identifying and contact information of the complainant, as well as the identifying and contact information of the filed against entity (FAE). This information enables CMS to respond to the complainant and gather more information if necessary, and to contact the FAE to discuss the complaint and CMS' findings. Form Number. CMS-10148 (OMB control number. 0938-0948). Frequency. Where can I keep Kamagra?Keep out of reach of children. Store at room temperature between 15 and 30 degrees C (59 and 86 degrees F). Throw away any unused medicine after the expiration date. Kamagra uk next dayHow to cite https://mycopd-blog.com/2020/05/25/yes-yes-yes/ this kamagra uk next day article:Singh OP. The National Commission for Allied and Healthcare Professions Act, 2020 and its implication for mental health. Indian J Psychiatry 2021;63:119-20The kamagra uk next day National Commission for Allied and Healthcare Professions Act, 2020 has been notified on March 28, 2021, by the Gazette of India published by the Ministry of Law and Justice. This bill aims to âÂÂprovide for regulation and maintenance of standards of education and services by allied and healthcare professionals, assessment of institutions, maintenance of a Central Register and State Register and creation of a system to improve access, research and development and adoption of latest scientific advancement and for matters connected therewith or incidental thereto.âÂÂ[1]This act has created a category of Health Care Professionals which is defined as. ÃÂÂhealthcare professionalâ includes a scientist, therapist, or other professional who studies, advises, researches, supervises or provides preventive, curative, rehabilitative, therapeutic or promotional health services and who has obtained any qualification of degree under this Act, the duration of which shall not be <3600 h spread over a period of 3 years to 6 years divided into specific semesters.[1]According to the act, âÂÂAllied health professionalâ includes an associate, technician, or technologist who is trained to kamagra uk next day perform any technical and practical task to support diagnosis and treatment of illness, disease, injury or impairment, and to support implementation of any healthcare treatment and referral plan recommended by a medical, nursing, or any other healthcare professional, and who has obtained any qualification of diploma or degree under this Act, the duration of which shall not be less than 2000 h spread over a period of 2 years to 4 years divided into specific semesters.âÂÂ[1]It is noticeable that while the term âÂÂHealth Care Professionalsâ does not include doctors who are registered under National Medical Council, Mental Health Care Act (MHCA), 2017 includes psychiatrists under the ambit of Mental Health Care Professionals.[2] This discrepancy needs to be corrected - psychiasts, being another group of medical specialists, should be kept out of the broad umbrella of âÂÂMental Healthcare Professionals.âÂÂThe category of Behavioural Health Sciences Professional has been included and defined as âÂÂa person who undertakes scientific study of the emotions, behaviours and biology relating to a person's mental well-being, their ability to function in everyday life and their concept of self. ÃÂÂBehavioural healthâ is the preferred term to âÂÂmental healthâ and includes professionals such as counselors, analysts, psychologists, educators and support workers, who provide counseling, therapy, and mediation services to individuals, families, groups, and communities in response to social and personal difficulties.âÂÂ[1]This is a welcome step to the extent that it creates a diverse category of trained workforce in the field of Mental Health (Behavioural Health Science Professionals) and tries to regulate their training although it mainly aims to promote mental wellbeing. However there is a huge lacuna in the term of âÂÂMental Illnessâ as defined by MHCA, kamagra uk next day 2017. Only severe disorders are included as per definition and there is no clarity regarding inclusion of other psychiatric disorders, namely âÂÂcommon mental disordersâ such as anxiety and depression. This leaves a strong kamagra uk next day possibility of concept of âÂÂpsychiatric illnessesâ being limited to only âÂÂsevere psychiatric disordersâ (major psychoses) thus perpetuating the stigma and alienation associated with psychiatric patients for centuries. Psychiatrists being restricted to treating severe mental disorders as per MHCA, 2017, there is a strong possibility that the care of common mental disorders may gradually pass on under the care of âÂÂbehavioural health professionalsâ as per the new act!. There is need to look into this aspect by the leadership in psychiatry, both organizational and kamagra uk next day academic psychiatry, and reduce the contradictions between the MHCA, 2017 and this nascent act. All disorders classified in ICD 10 and DSM 5 should be classified as âÂÂPsychiatric Disordersâ or âÂÂMental Illness.â This will not only help in fighting the stigma associated with psychiatric illnesses but also promote the integration of psychiatry with other specialties. References 1.The National kamagra uk next day Commission for Allied and Healthcare Professions Act, 2021. The Gazette of India. Published by Ministry of kamagra uk next day Law and Justice. 28 March, 2021. 2.The Mental Healthcare Act, 2017 kamagra uk next day. The Gazette of India. Published by kamagra uk next day Ministry of Law and Justice. April 7, 2017. Correspondence Address:Om Prakash SinghAA 304, kamagra uk next day Ashabari Apartments, O/31, Baishnabghata, Patuli Township, Kolkata - 700 094, West Bengal IndiaSource of Support. None, Conflict of Interest. NoneDOI. 10.4103/indianjpsychiatry.indianjpsychiatry_268_21Abstract Thiamine kamagra uk next day is essential for the activity of several enzymes associated with energy metabolism in humans. Chronic alcohol use is associated with deficiency of thiamine along with other vitamins through several mechanisms. Several neuropsychiatric syndromes have been associated with thiamine deficiency kamagra uk next day in the context of alcohol use disorder including WernickeâÂÂKorsakoff syndrome, alcoholic cerebellar syndrome, alcoholic peripheral neuropathy, and possibly, MarchiafavaâÂÂBignami syndrome. High-dose thiamine replacement is suggested for these neuropsychiatric syndromes.Keywords. Alcohol use disorder, alcoholic cerebellar syndrome, alcoholic peripheral neuropathy, MarchiafavaâÂÂBignami syndrome, thiamine, WernickeâÂÂKorsakoff syndromeHow to cite this article:Praharaj SK, Munoli RN, Shenoy S, kamagra uk next day Udupa ST, Thomas LS. High-dose thiamine strategy in WernickeâÂÂKorsakoff syndrome and related thiamine deficiency conditions associated with alcohol use disorder. Indian J Psychiatry 2021;63:121-6How kamagra uk next day to cite this URL:Praharaj SK, Munoli RN, Shenoy S, Udupa ST, Thomas LS. High-dose thiamine strategy in WernickeâÂÂKorsakoff syndrome and related thiamine deficiency conditions associated with alcohol use disorder. Indian J Psychiatry [serial online] 2021 kamagra uk next day [cited 2021 May 25];63:121-6. Available from. Https://www.indianjpsychiatry.org/text.asp?. 2021/63/2/121/313716 Introduction Thiamine is a water-soluble vitamin (B1) that plays a key role in the activity of several enzymes associated with energy metabolism. Thiamine pyrophosphate (or diphosphate) is the active form that acts as a cofactor for enzymes. The daily dietary requirement of thiamine in adults is 1âÂÂ2 mg and is dependent on carbohydrate intake.[1],[2] The requirement increases if basal metabolic rate is higher, for example, during alcohol withdrawal state. Dietary sources include pork (being the major source), meat, legume, vegetables, and enriched foods. The body can store between 30 and 50 mg of thiamine and is likely to get depleted within 4âÂÂ6 weeks if the diet is deficient.[2] In those with alcohol-related liver damage, the ability to store thiamine is gradually reduced.[1],[2]Lower thiamine levels are found in 30%âÂÂ80% of chronic alcohol users.[3] Thiamine deficiency occurs due to poor intake of vitamin-rich foods, impaired intestinal absorption, decreased storage capacity of liver, damage to the renal epithelial cells due to alcohol, leading to increased loss from the kidneys, and excessive loss associated with medical conditions.[2],[3] Furthermore, alcohol decreases the absorption of colonic bacterial thiamine, reduces the enzymatic activity of thiamine pyrophosphokinase, and thereby, reducing the amount of available thiamine pyrophosphate.[4] Since facilitated diffusion of thiamine into cells is dependent on a concentration gradient, reduced thiamine pyrophosphokinase activity further reduces thiamine uptake into cells.[4] Impaired utilization of thiamine is seen in certain conditions (e.g., hypomagnesemia) which are common in alcohol use disorder.[2],[3],[4] This narrative review discusses the neuropsychiatric syndromes associated with thiamine deficiency in the context of alcohol use disorder, and the treatment regimens advocated for these conditions. A PubMed search supplemented with manual search was used to identify neuropsychiatric syndromes related to thiamine deficiency in alcohol use disorder patients. Neuropsychiatric Syndromes Associated With Thiamine Deficiency WernickeâÂÂKorsakoff syndromeWernicke encephalopathy is associated with chronic alcohol use, and if not identified and treated early, could lead to permanent brain damage characterized by an amnestic syndrome known as Korsakoff syndrome. Inappropriate treatment of Wernicke encephalopathy with lower doses of thiamine can lead to high mortality rates (~20%) and Korsakoff syndrome in ~ 80% of patients (ranges from 56% to 84%).[5],[6] The classic triad of Wernicke includes oculomotor abnormalities, cerebellar dysfunction, and confusion. Wernicke lesions are found in 12.5% of brain samples of patients with alcohol dependence.[7] However, only 20%âÂÂ30% of them had a clinical diagnosis of Wernicke encephalopathy antemortem. It has been found that many patients develop WernickeâÂÂKorsakoff syndrome (WKS) following repeated subclinical episodes of thiamine deficiency.[7] In an autopsy report of 97 chronic alcohol users, only16% had all the three âÂÂclassical signs,â 29% had two signs, 37% presented with one sign, and 19% had none.[8] Mental status changes are the most prevalent sign (seen in 82% of the cases), followed by eye signs (in 29%) and ataxia (23%).[8] WKS should be suspected in persons with a history of alcohol use and presenting with signs of ophthalmoplegia, ataxia, acute confusion, memory disturbance, unexplained hypotension, hypothermia, coma, or unconsciousness.[9] Operational criteria for the diagnosis of Wernicke encephalopathy have been proposed by Caine et al.[10] that requires two out of four features, i.e., (a) dietary deficiency (signs such as cheilitis, glossitis, and bleeding gums), (b) oculomotor abnormalities (nystagmus, opthalmoplegia, and diplopia), (c) cerebellar dysfunction (gait ataxia, nystagmus), and (d) either altered mental state (confusion) or mild memory impairment.As it is very difficult to clinically distinguish Wernicke encephalopathy from other associated conditions such as delirium tremens, hepatic encephalopathy, or head injury, it is prudent to have a lower threshold to diagnose this if any of the clinical signs is seen. Magnetic resonance imaging (MRI) brain scan during Wernicke encephalopathy shows mammillary body atrophy and enlarged third ventricle, lesions in the medial portions of thalami and mid brain and can be used to aid diagnosis.[11],[12] However, most clinical situations warrant treatment without waiting for neuroimaging report. The treatment suggestions in the guidelines vary widely. Furthermore, hardly any evidence-based recommendations exist on a more general use of thiamine as a preventative intervention in individuals with alcohol use disorder.[13] There are very few studies that have evaluated the dose and duration of thiamine for WKS, but higher doses may result in a greater response.[6],[14] With thiamine administration rapid improvement is seen in eye movement abnormalities (improve within days or weeks) and ataxia (may take months to recover), but the effects on memory, in particular, are unclear.[4],[14] Severe memory impairment is the core feature of Korsakoff syndrome. Initial stages of the disease can present with confabulation, executive dysfunction, flattened affect, apathy, and poor insight.[15] Both the episodic and semantic memory are affected, whereas, procedural memory remains intact.[15]Thomson et al.[6] suggested the following should be treated with thiamine as they are at high risk for developing WKS. (1) all patients with any evidence of chronic alcohol misuse and any of the following. Acute confusion, decreased conscious level, ataxia, ophthalmoplegia, memory disturbance, and hypothermia with hypotension. (2) patients with delirium tremens may often also have Wernicke encephalopathy, therefore, all of these patients should be presumed to have Wernicke encephalopathy and treated, preferably as inpatients. And (3) all hypoglycemic patients (who are treated with intravenous glucose) with evidence of chronic alcohol ingestion must be given intravenous thiamine immediately because of the risk of acutely precipitating Wernicke encephalopathy.Alcoholic cerebellar syndromeChronic alcohol use is associated with the degeneration of anterior superior vermis, leading to a clinical syndrome characterized by the subacute or chronic onset of gait ataxia and incoordination in legs, with relative sparing of upper limbs, speech, and oculomotor movements.[16] In severe cases, truncal ataxia, mild dysarthria, and incoordination of the upper limb is also found along with gait ataxia. Thiamine deficiency is considered to be the etiological factor,[17],[18] although direct toxic effects of alcohol may also contribute to this syndrome. One-third of patients with chronic use of alcohol have evidence of alcoholic cerebellar degeneration. However, population-based studies estimate prevalence to be 14.6%.[19] The effect of alcohol on the cerebellum is graded with the most severe deficits occurring in alcohol users with the longest duration and highest severity of use. The diagnosis of cerebellar degeneration is largely clinical. MRI can be used to evaluate for vermian atrophy but is unnecessary.[20] Anterior portions of vermis are affected early, with involvement of posterior vermis and adjacent lateral hemispheres occurring late in the course could be used to differentiate alcoholic cerebellar degeneration from other conditions that cause more diffuse involvement.[21] The severity of cerebellar syndrome is more in the presence of WKS, thus could be related to thiamine deficiency.[22],[23] Therefore, this has been considered as a cerebellar presentation of WKS and should be treated in a similar way.[16] There are anecdotal evidence to suggest improvement in cerebellar syndrome with high-dose thiamine.[24]Alcoholic peripheral neuropathyPeripheral neuropathy is common in alcohol use disorder and is seen in 44% of the users.[25] It has been associated predominantly with thiamine deficiency. However, deficiency of other B vitamins (pyridoxine and cobalamin) and direct toxic effect of alcohol is also implicated.[26] Clinically, onset of symptoms is gradual with the involvement of both sensory and motor fibers and occasionally autonomic fibers. Neuropathy can affect both small and large peripheral nerve fibers, leading to different clinical manifestations. Thiamine deficiency-related neuropathy affects larger fiber types, which results in motor deficits and sensory ataxia. On examination, large fiber involvement is manifested by distal limb muscle weakness and loss of proprioception and vibratory sensation. Together, these can contribute to the gait unsteadiness seen in chronic alcohol users by creating a superimposed steppage gait and reduced proprioceptive input back to the movement control loops in the central nervous system. The most common presentations include painful sensations in both lower limbs, sometimes with burning sensation or numbness, which are early symptoms. Typically, there is a loss of vibration sensation in distal lower limbs. Later symptoms include loss of proprioception, gait disturbance, and loss of reflexes. Most advanced findings include weakness and muscle atrophy.[20] Progression is very gradual over months and involvement of upper limbs may occur late in the course. Diagnosis begins with laboratory evaluation to exclude other causes of distal, sensorimotor neuropathy including hemoglobin A1c, liver function tests, and complete blood count to evaluate for red blood cell macrocytosis. Cerebrospinal fluid studies may show increased protein levels but should otherwise be normal in cases of alcohol neuropathy and are not recommended in routine evaluation. Electromyography and nerve conduction studies can be used to distinguish whether the neuropathy is axonal or demyelinating and whether it is motor, sensory, or mixed type. Alcoholic neuropathy shows reduced distal, sensory amplitudes, and to a lesser extent, reduced motor amplitudes on nerve conduction studies.[20] Abstinence and vitamin supplementation including thiamine are the treatments advocated for this condition.[25] In mild-to-moderate cases, near-complete improvement can be achieved.[20] Randomized controlled trials have showed a significant improvement in alcoholic polyneuropathy with thiamine treatment.[27],[28]MarchiafavaâÂÂBignami syndromeThis is a rare but fatal condition seen in chronic alcohol users that is characterized by progressive demyelination and necrosis of the corpus callosum. The association of this syndrome with thiamine deficiency is not very clear, and direct toxic effects of alcohol are also suggested.[29] The clinical syndrome is variable and presentation can be acute, subacute, or chronic. In acute forms, it is predominantly characterized by the altered mental state such as delirium, stupor, or coma.[30] Other clinical features in neuroimaging confirmed MarchiafavaâÂÂBignami syndrome (MBS) cases include impaired gait, dysarthria, mutism, signs of split-brain syndrome, pyramidal tract signs, primitive reflexes, rigidity, incontinence, gaze palsy, diplopia, and sensory symptoms.[30] Neuropsychiatric manifestations are common and include psychotic symptoms, depression, apathy, aggressive behavior, and sometimes dementia.[29] MRI scan shows lesions of the corpus callosum, particularly splenium. Treatment for this condition is mostly supportive and use of nutritional supplements and steroids. However, there are several reports of improvement of this syndrome with thiamine at variable doses including reports of beneficial effects with high-dose strategy.[29],[30],[31] Early initiation of thiamine, preferably within 2 weeks of the onset of symptoms is associated with a better outcome. Therefore, high-dose thiamine should be administered to all suspected cases of MBS. Laboratory Diagnosis of Thiamine Deficiency Estimation of thiamine and thiamine pyrophosphate levels may confirm the diagnosis of deficiency. Levels of thiamine in the blood are not reliable indicators of thiamine status. Low erythrocyte transketolase activity is also helpful.[32],[33] Transketolase concentrations of <120 nmol/L have also been used to indicate deficiency, while concentrations of 120âÂÂ150 nmol/L suggest marginal thiamine status.[1] However, these tests are not routinely performed as it is time consuming, expensive, and may not be readily available.[34] The ETKA assay is a functional test rather than a direct measurement of thiamin status and therefore may be influenced by factors other than thiamine deficiency such as diabetes mellitus and polyneuritis.[1] Hence, treatment should be initiated in the absence of laboratory confirmation of thiamine deficiency. Furthermore, treatment should not be delayed if tests are ordered, but the results are awaited. Electroencephalographic abnormalities in thiamine deficiency states range from diffuse mild-to-moderate slow waves and are not a good diagnostic option, as the prevalence of abnormalities among patients is inconsistent.[35]Surrogate markers, which reflect chronic alcohol use and nutritional deficiency other than thiamine, may be helpful in identifying at-risk patients. This includes gamma glutamate transferase, aspartate aminotransferase. Alanine transaminase ratio >2:1, and increased mean corpuscular volume.[36] They are useful when a reliable history of alcohol use is not readily available, specifically in emergency departments when treatment needs to be started immediately to avoid long-term consequences. Thiamine Replacement Therapy Oral versus parenteral thiamineIntestinal absorption of thiamine depends on active transport through thiamine transporter 1 and 2, which follow saturation kinetics.[1] Therefore, the rate and amount of absorption of thiamine in healthy individuals is limited. In healthy volunteers, a 10 mg dose results in maximal absorption of thiamine, and any doses higher than this do not increase thiamine levels. Therefore, the maximum amount of thiamine absorbed from 10 mg or higher dose is between 4.3 and 5.6 mg.[37] However, it has been suggested that, although thiamine transport occurs through the energy-requiring, sodium-dependent active process at physiologic concentrations, at higher supraphysiologic concentrations thiamine uptake is mostly a passive process.[38] Smithline et al. Have demonstrated that it is possible to achieve higher serum thiamine levels with oral doses up to 1500 mg.[39]In chronic alcohol users, intestinal absorption is impaired. Hence, absorption rates are expected to be much lower. It is approximately 30% of that seen in healthy individuals, i.e., 1.5 mg of thiamine is absorbed from 10 mg oral thiamine.[3] In those consuming alcohol and have poor nutrition, not more than 0.8 mg of thiamine is absorbed.[2],[3],[6] The daily thiamine requirement is 1âÂÂ1.6 mg/day, which may be more in alcohol-dependent patients at risk for Wernicke encephalopathy.[1] It is highly likely that oral supplementation with thiamine will be inadequate in alcohol-dependent individuals who continue to drink. Therefore, parenteral thiamine is preferred for supplementation in deficiency states associated with chronic alcohol use. Therapy involving parenteral thiamine is considered safe except for occasional circumstances of allergic reactions involving pruritus and local irritation.There is a small, but definite risk of anaphylaxis with parenteral thiamine, specifically with intravenous administration (1/250,000 intravenous injections).[40] Diluting thiamine in 50âÂÂ100 mg normal saline for infusion may reduce the risk. However, parenteral thiamine should always be administered under observation with the necessary facilities for resuscitation.A further important issue involves the timing of administration of thiamine relative to the course of alcohol abuse or dependence. Administration of thiamine treatment to patients experiencing alcohol withdrawal may also be influenced by other factors such as magnesium depletion, N-methyl-D-aspartate (NMDA) receptor upregulation, or liver impairment, all of which may alter thiamine metabolism and utilization.[6],[14]Thiamine or other preparations (e.g., benfotiamine)The thiamine transporters limit the rate of absorption of orally administered thiamine. Allithiamines (e.g., benfotiamine) are the lipid-soluble thiamine derivatives that are absorbed better, result in higher thiamine levels, and are retained longer in the body.[41] The thiamine levels with orally administered benfotiamine are much higher than oral thiamine and almost equals to intravenous thiamine given at the same dosage.[42]Benfotiamine has other beneficial effects including inhibition of production of advanced glycation end products, thus protecting against diabetic vascular complications.[41] It also modulates nuclear transcription factor úB (NK-úB), vascular endothelial growth factor receptor 2, glycogen synthase kinase 3 ò, etc., that play a role in cell repair and survival.[41] Benfotiamine has been found to be effective for the treatment of alcoholic peripheral neuropathy.[27]Dosing of thiamineAs the prevalence of thiamine deficiency is very common in chronic alcohol users, the requirement of thiamine increases in active drinkers and it is difficult to rapidly determine thiamine levels using laboratory tests, it is prudent that all patients irrespective of nutritional status should be administered parenteral thiamine. The dose should be 100 mg thiamine daily for 3âÂÂ5 days during inpatient treatment. Commonly, multivitamin injections are added to intravenous infusions. Patients at risk for thiamine deficiency should receive 250 mg of thiamine daily intramuscularly for 3âÂÂ5 days, followed by oral thiamine 100 mg daily.[6]Thiamine plasma levels reduce to 20% of peak value after approximately 2 h of parenteral administration, thus reducing the effective âÂÂwindow periodâ for passive diffusion to the central nervous system.[6] Therefore, in thiamine deficient individuals with features of Wernicke encephalopathy should receive thiamine thrice daily.High-dose parenteral thiamine administered thrice daily has been advocated in patients at risk for Wernicke encephalopathy.[43] The Royal College of Physicians guideline recommends that patients with suspected Wernicke encephalopathy should receive 500 mg thiamine diluted in 50âÂÂ100 ml of normal saline infusion over 30 min three times daily for 2âÂÂ3 days and sometimes for longer periods.[13] If there are persistent symptoms such as confusion, cerebellar symptoms, or memory impairment, this regimen can be continued until the symptoms improve. If symptoms improve, oral thiamine 100 mg thrice daily can be continued for prolonged periods.[6],[40] A similar treatment regimen is advocated for alcoholic cerebellar degeneration as well. Doses more than 500 mg intramuscular or intravenous three times a day for 3âÂÂ5 days, followed by 250 mg once daily for a further 3âÂÂ5 days is also recommended by some guidelines (e.g., British Association for Psychopharmacology).[44]Other effects of thiamineThere are some data to suggest that thiamine deficiency can modulate alcohol consumption and may result in pathological drinking. Benfotiamine 600 mg/day as compared to placebo for 6 months was well tolerated and found to decrease psychiatric distress in males and reduce alcohol consumption in females with severe alcohol dependence.[45],[46] Other Factors During Thiamine Therapy Correction of hypomagnesemiaMagnesium is a cofactor for many thiamine-dependent enzymes in carbohydrate metabolism. Patients may fail to respond to thiamine supplementation in the presence of hypomagnesemia.[47] Magnesium deficiency is common in chronic alcohol users and is seen in 30% of individuals.[48],[49] It can occur because of increased renal excretion of magnesium, poor intake, decreased absorption because of Vitamin D deficiency, the formation of undissociated magnesium soaps with free fatty acids.[48],[49]The usual adult dose is 35âÂÂ50 mmol of magnesium sulfate added to 1 L isotonic (saline) given over 12âÂÂ24 h.[6] The dose has to be titrated against plasma magnesium levels. It is recommended to reduce the dose in renal failure. Contraindications include patients with documented hypersensitivity and those with heart block, Addison's disease, myocardial damage, severe hepatitis, or hypophosphatemia. Do not administer intravenous magnesium unless hypomagnesemia is confirmed.[6]Other B-complex vitaminsMost patients with deficiency of thiamine will also have reduced levels of other B vitamins including niacin, pyridoxine, and cobalamin that require replenishment. For patients admitted to the intensive care unit with symptoms that may mimic or mask Wernicke encephalopathy, based on the published literature, routine supplementation during the 1st day of admission includes 200âÂÂ500 mg intravenous thiamine every 8 h, 64 mg/kg magnesium sulfate (âÂÂ4âÂÂ5 g for most adult patients), and 400âÂÂ1000 üg intravenous folate.[50] If alcoholic ketoacidosis is suspected, dextrose-containing fluids are recommended over normal saline.[50] Precautions to be Taken When Administering Parenteral Thiamine It is recommended to monitor for anaphylaxis and has appropriate facilities for resuscitation and for treating anaphylaxis readily available including adrenaline and corticosteroids. Anaphylaxis has been reported at the rate of approximately 4/1 million pairs of ampoules of Pabrinex (a pair of high potency vitamins available in the UK containing 500 mg of thiamine (1:250,000 I/V administrations).[40] Intramuscular thiamine is reported to have a lower incidence of anaphylactic reactions than intravenous administration.[40] The reaction has been attributed to nonspecific histamine release.[51] Administer intravenous thiamine slowly, preferably by slow infusion in 100 ml normal saline over 15âÂÂ30 min. Conclusions Risk factors for thiamine deficiency should be assessed in chronic alcohol users. A high index of suspicion and a lower threshold to diagnose thiamine deficiency states including Wernicke encephalopathy is needed. Several other presentations such as cerebellar syndrome, MBS, polyneuropathy, and delirium tremens could be related to thiamine deficiency and should be treated with protocols similar to Wernicke encephalopathy. High-dose thiamine is recommended for the treatment of suspected Wernicke encephalopathy and related conditions [Figure 1]. However, evidence in terms of randomized controlled trials is lacking, and the recommendations are based on small studies and anecdotal reports. Nevertheless, as all these conditions respond to thiamine supplementation, it is possible that these have overlapping pathophysiology and are better considered as Wernicke encephalopathy spectrum disorders.Figure 1. Thiamine recommendations for patients with alcohol use disorder. AHistory of alcohol use, but no clinical features of WE. BNo clinical features of WE, but with risk factors such as complicated withdrawal (delirium, seizures). CClinical features of WE (ataxia, opthalmoplegia, global confusion)Click here to viewFinancial support and sponsorshipNil.Conflicts of interestThere are no conflicts of interest. References 1.Frank LL. Thiamin in clinical practice. JPEN J Parenter Enteral Nutr 2015;39:503-20. 2.Thomson AD, Marshall EJ. The natural history and pathophysiology of Wernicke's Encephalopathy and Korsakoff's Psychosis. Alcohol Alcohol 2006;41:151-8. 3.Thomson AD, Guerrini I, Marshall EJ. Wernicke's encephalopathy. Role of thiamine. Pract Gastroenterol 2009;33:21-30. 4.Isenberg-Grzeda E, Kutner HE, Nicolson SE. Wernicke-Korsakoff-syndrome. Under-recognized and under-treated. Psychosomatics 2012;53:507-16. 5.Wood B, Currie J, Breen K. Wernicke's encephalopathy in a metropolitan hospital. A prospective study of incidence, characteristics and outcome. Med J Aust 1986;144:12-6. 6.Thomson AD, Cook CC, Touquet R, Henry JA, Royal College of Physicians, London. The Royal College of Physicians report on alcohol. Guidelines for managing Wernicke's encephalopathy in the accident and Emergency Department. Alcohol Alcohol 2002;37:513-21. 7.Harper C. Thiamine (vitamin B1) deficiency and associated brain damage is still common throughout the world and prevention is simple and safe!. Eur J Neurol 2006;13:1078-82. 8.Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex. A retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986;49:341-5. 9.Cook CC. Prevention and treatment of Wernicke-Korsakoff syndrome. Alcohol Alcohol 2000;35:19-20. 10.Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification cheapest kamagra oral jelly online of chronic alcoholics. Identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 1997;62:51-60. 11.Sullivan EV, Pfefferbaum A. Neuroimaging of the Wernicke-Korsakoff syndrome. Alcohol Alcohol 2009;44:155-65. 12.Jung YC, Chanraud S, Sullivan EV. Neuroimaging of Wernicke's encephalopathy and Korsakoff's syndrome. Neuropsychol Rev 2012;22:170-80. 13.Pruckner N, Baumgartner J, Hinterbuchinger B, Glahn A, Vyssoki S, Vyssoki B. Thiamine substitution in alcohol use disorder. A narrative review of medical guidelines. Eur Addict Res 2019;25:103-10. 14.Day E, Bentham PW, Callaghan R, Kuruvilla T, George S. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev 2013;7:CD004033. Doi. 10.1002/14651858.CD004033.pub3. 15.Arts NJ, Walvoort SJ, Kessels RP. Korsakoff's syndrome. A critical review. Neuropsychiatr Dis Treat 2017;13:2875-90. 16.Laureno R. Nutritional cerebellar degeneration, with comments on its relationship to Wernicke disease and alcoholism. Handb Clin Neurol 2012;103:175-87. 17.Maschke M, Weber J, Bonnet U, Dimitrova A, Bohrenkämper J, Sturm S, et al. Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI. J Neurol 2005;252:704-11. 18.Mulholland PJ, Self RL, Stepanyan TD, Little HJ, Littleton JM, Prendergast MA. Thiamine deficiency in the pathogenesis of chronic ethanol-associated cerebellar damage in vitro. Neuroscience 2005;135:1129-39. 19.Del Brutto OH, Mera RM, Sullivan LJ, Zambrano M, King NR. Population-based study of alcoholic cerebellar degeneration. The Atahualpa Project. J Neurol Sci 2016;367:356-60. 20.Hammoud N, Jimenez-Shahed J. Chronic neurologic effects of alcohol. Clin Liver Dis 2019;23:141-55. 21.Lee JH, Heo SH, Chang DI. Early-stage alcoholic cerebellar degeneration. Diagnostic imaging clues. J Korean Med Sci 2015;30:1539. 22.Phillips SC, Harper CG, Kril JJ. The contribution of Wernicke's encephalopathy to alcohol-related cerebellar damage. Drug Alcohol Rev 1990;9:53-60. 23.Baker KG, Harding AJ, Halliday GM, Kril JJ, Harper CG. Neuronal loss in functional zones of the cerebellum of chronic alcoholics with and without Wernicke's encephalopathy. Neuroscience 1999;91:429-38. 24.Graham JR, Woodhouse D, Read FH. Massive thiamine dosage in an alcoholic with cerebellar cortical degeneration. Lancet 1971;2:107. 25.Julian T, Glascow N, Syeed R, Zis P. Alcohol-related peripheral neuropathy. A systematic review and meta-analysis. J Neurol 2018;22:1-3. 26.Chopra K, Tiwari V. Alcoholic neuropathy. Possible mechanisms and future treatment possibilities. Br J Clin Pharmacol 2012;73:348-62. 27.Woelk H, Lehrl S, Bitsch R, Köpcke W. Benfotiamine in treatment of alcoholic polyneuropathy. An 8-week randomized controlled study (BAP I Study). Alcohol Alcohol 1998;33:631-8. 28.Peters TJ, Kotowicz J, Nyka W, Kozubski W, Kuznetsov V, Vanderbist F, et al. Treatment of alcoholic polyneuropathy with vitamin B complex. A randomised controlled trial. Alcohol Alcohol 2006;41:636-42. 29.Fernandes LM, Bezerra FR, Monteiro MC, Silva ML, de Oliveira FR, Lima RR, et al. Thiamine deficiency, oxidative metabolic pathways and ethanol-induced neurotoxicity. How poor nutrition contributes to the alcoholic syndrome, as Marchiafava-Bignami disease. Eur J Clin Nutr 2017;71:580-6. 30.Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of Marchiafava-Bignami disease. A review of CT/MRI confirmed cases. J Neurol Neurosurg Psychiatry 2014;85:168-73. 31.Nemlekar SS, Mehta RY, Dave KR, Shah ND. Marchiafava. Bignami disease treated with parenteral thiamine. Indian J Psychol Med 2016;38:147-9. [Full text] 32.Brin M. Erythrocyte transketolase in early thiamine deficiency. Ann N Y Acad Sci 1962;98:528-41. 33.Dreyfus PM. Clinical application of blood transketolase determinations. N Engl J Med 1962;267:596-8. 34.Edwards KA, Tu-Maung N, Cheng K, Wang B, Baeumner AJ, Kraft CE. Thiamine assays â Advances, challenges, and caveats. ChemistryOpen 2017;6:178-91. 35.Chandrakumar A, Bhardwaj A, 't Jong GW. Review of thiamine deficiency disorders. Wernicke encephalopathy and Korsakoff psychosis. J Basic Clin Physiol Pharmacol 2018;30:153-62. 36.Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol 2014;20:11684-99. 37.Thomson AD, Leevy CM. Observations on the mechanism of thiamine hydrochloride absorption in man. Clin Sci 1972;43:153-63. 38.Hoyumpa AM Jr., Strickland R, Sheehan JJ, Yarborough G, Nichols S. Dual system of intestinal thiamine transport in humans. J Lab Clin Med 1982;99:701-8. 39.Smithline HA, Donnino M, Greenblatt DJ. Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects. BMC Clin Pharmacol 2012;12:4. 40.Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J 2014;44:911-5. 41.Raj V, Ojha S, Howarth FC, Belur PD, Subramanya SB. Therapeutic potential of benfotiamine and its molecular targets. Eur Rev Med Pharmacol Sci 2018;22:3261-73. 42.Xie F, Cheng Z, Li S, Liu X, Guo X, Yu P, et al. Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride. J Clin Pharmacol 2014;54:688-95. 43.Cook CC, Hallwood PM, Thomson AD. B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol 1998;33:317-36. 44.Lingford-Hughes AR, Welch S, Peters L, Nutt DJ, British Association for Psychopharmacology, Expert Reviewers Group. BAP updated guidelines. Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity. Recommendations from BAP. J Psychopharmacol 2012;26:899-952. 45.Manzardo AM, He J, Poje A, Penick EC, Campbell J, Butler MG. Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence. Drug Alcohol Depend 2013;133:562-70. 46.Manzardo AM, Pendleton T, Poje A, Penick EC, Butler MG. Change in psychiatric symptomatology after benfotiamine treatment in males is related to lifetime alcoholism severity. Drug Alcohol Depend 2015;152:257-63. 47.Dingwall KM, Delima JF, Gent D, Batey RG. Hypomagnesaemia and its potential impact on thiamine utilisation in patients with alcohol misuse at the Alice Springs Hospital. Drug Alcohol Rev 2015;34:323-8. 48.Flink EB. Magnesium deficiency in alcoholism. Alcohol Clin Exp Res 1986;10:590-4. 49.Grochowski C, Blicharska E, Baj J, Mierzwià Âska A, Brzozowska K, Forma A, et al. Serum iron, magnesium, copper, and manganese levels in alcoholism. A systematic review. Molecules 2019;24:E1361. 50.Flannery AH, Adkins DA, Cook AM. Unpeeling the evidence for the banana bag. Evidence-based recommendations for the management of alcohol-associated vitamin and electrolyte deficiencies in the ICU. Crit Care Med 2016;44:1545-52. 51.Lagunoff D, Martin TW, Read G. Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol 1983;23:331-51. Correspondence Address:Samir Kumar PraharajDepartment of Psychiatry, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka IndiaSource of Support. None, Conflict of Interest. NoneDOI. 10.4103/psychiatry.IndianJPsychiatry_440_20 Figures [Figure 1]. How to kamagra online without prescription cite this article:Singh http://wvlpac.com/ OP. The National Commission for Allied and Healthcare Professions Act, 2020 and its implication for mental health. Indian J Psychiatry 2021;63:119-20The National Commission for Allied and kamagra online without prescription Healthcare Professions Act, 2020 has been notified on March 28, 2021, by the Gazette of India published by the Ministry of Law and Justice. This bill aims to âÂÂprovide for regulation and maintenance of standards of education and services by allied and healthcare professionals, assessment of institutions, maintenance of a Central Register and State Register and creation of a system to improve access, research and development and adoption of latest scientific advancement and for matters connected therewith or incidental thereto.âÂÂ[1]This act has created a category of Health Care Professionals which is defined as. ÃÂÂhealthcare professionalâ includes a scientist, therapist, or other professional who studies, advises, researches, supervises or provides preventive, curative, rehabilitative, therapeutic or promotional health services and who has obtained any qualification of degree under this Act, the duration of which shall not be <3600 h spread over a period of 3 years to 6 years divided into specific semesters.[1]According to the act, âÂÂAllied health professionalâ includes an associate, technician, or technologist who is trained to perform any technical and practical task to support diagnosis and treatment of illness, disease, injury or impairment, and to support implementation of any healthcare treatment and referral plan recommended by a medical, nursing, or any other healthcare professional, and who has obtained any qualification of diploma or degree under this Act, the duration of which shall not be less than 2000 h spread over a period of 2 years to 4 years divided into specific semesters.âÂÂ[1]It is noticeable that while the term âÂÂHealth Care Professionalsâ does not include doctors who are registered under National Medical Council, Mental Health Care Act (MHCA), 2017 includes psychiatrists under the ambit of Mental Health Care Professionals.[2] This discrepancy needs to be corrected - psychiasts, being another group of medical specialists, should be kept out of the broad umbrella of âÂÂMental Healthcare Professionals.âÂÂThe category of Behavioural Health Sciences Professional has been included and defined as âÂÂa person who undertakes scientific study of the emotions, behaviours and biology relating to a person's kamagra online without prescription mental well-being, their ability to function in everyday life and their concept of self. ÃÂÂBehavioural healthâ is the preferred term to âÂÂmental healthâ and includes professionals such as counselors, analysts, psychologists, educators and support workers, who provide counseling, therapy, and mediation services to individuals, families, groups, and communities in response to social and personal difficulties.âÂÂ[1]This is a welcome step to the extent that it creates a diverse category of trained workforce in the field of Mental Health (Behavioural Health Science Professionals) and tries to regulate their training although it mainly aims to promote mental wellbeing. However there is a huge lacuna in the kamagra online without prescription term of âÂÂMental Illnessâ as defined by MHCA, 2017. Only severe disorders are included as per definition and there is no clarity regarding inclusion of other psychiatric disorders, namely âÂÂcommon mental disordersâ such as anxiety and depression. This leaves a strong possibility of concept of âÂÂpsychiatric illnessesâ kamagra online without prescription being limited to only âÂÂsevere psychiatric disordersâ (major psychoses) thus perpetuating the stigma and alienation associated with psychiatric patients for centuries. Psychiatrists being restricted to treating severe mental disorders as per MHCA, 2017, there is a strong possibility that the care of common mental disorders may gradually pass on under the care of âÂÂbehavioural health professionalsâ as per the new act!. There is need to kamagra online without prescription look into this aspect by the leadership in psychiatry, both organizational and academic psychiatry, and reduce the contradictions between the MHCA, 2017 and this nascent act. All disorders classified in ICD 10 and DSM 5 should be classified as âÂÂPsychiatric Disordersâ or âÂÂMental Illness.â This will not only help in fighting the stigma associated with psychiatric illnesses but also promote the integration of psychiatry with other specialties. References 1.The National Commission kamagra online without prescription for Allied and Healthcare Professions Act, 2021. The Gazette of India. Published by Ministry kamagra online without prescription of Law and Justice. 28 March, 2021. 2.The Mental Healthcare Act, kamagra online without prescription 2017. The Gazette of India. Published by Ministry of Law and Justice kamagra online without prescription. April 7, 2017. Correspondence Address:Om Prakash SinghAA 304, Ashabari Apartments, O/31, Baishnabghata, Patuli Township, kamagra online without prescription Kolkata - 700 094, West Bengal IndiaSource of Support. None, Conflict of Interest. NoneDOI. 10.4103/indianjpsychiatry.indianjpsychiatry_268_21Abstract Thiamine is essential for the activity of several enzymes associated with energy metabolism kamagra online without prescription in humans. Chronic alcohol use is associated with deficiency of thiamine along with other vitamins through several mechanisms. Several neuropsychiatric syndromes have been associated with thiamine deficiency in the context of alcohol use disorder including WernickeâÂÂKorsakoff syndrome, alcoholic cerebellar syndrome, kamagra online without prescription alcoholic peripheral neuropathy, and possibly, MarchiafavaâÂÂBignami syndrome. High-dose thiamine replacement is suggested for these neuropsychiatric syndromes.Keywords. Alcohol use disorder, alcoholic cerebellar syndrome, alcoholic kamagra online without prescription peripheral neuropathy, MarchiafavaâÂÂBignami syndrome, thiamine, WernickeâÂÂKorsakoff syndromeHow to cite this article:Praharaj SK, Munoli RN, Shenoy S, Udupa ST, Thomas LS. High-dose thiamine strategy in WernickeâÂÂKorsakoff syndrome and related thiamine deficiency conditions associated with alcohol use disorder. Indian J Psychiatry 2021;63:121-6How to cite this kamagra online without prescription URL:Praharaj SK, Munoli RN, Shenoy S, Udupa ST, Thomas LS. High-dose thiamine strategy in WernickeâÂÂKorsakoff syndrome and related thiamine deficiency conditions associated with alcohol use disorder. Indian J Psychiatry [serial online] 2021 [cited 2021 kamagra online without prescription May 25];63:121-6. Available from. Https://www.indianjpsychiatry.org/text.asp?. 2021/63/2/121/313716 Introduction Thiamine is a water-soluble vitamin (B1) that plays a key role in the activity of several enzymes associated with energy metabolism. Thiamine pyrophosphate (or diphosphate) is the active form that acts as a cofactor for enzymes. The daily dietary requirement of thiamine in adults is 1âÂÂ2 mg and is dependent on carbohydrate intake.[1],[2] The requirement increases if basal metabolic rate is higher, for example, during alcohol withdrawal state. Dietary sources include pork (being the major source), meat, legume, vegetables, and enriched foods. The body can store between 30 and 50 mg of thiamine and is likely to get depleted within 4âÂÂ6 weeks if the diet is deficient.[2] In those with alcohol-related liver damage, the ability to store thiamine is gradually reduced.[1],[2]Lower thiamine levels are found in 30%âÂÂ80% of chronic alcohol users.[3] Thiamine deficiency occurs due to poor intake of vitamin-rich foods, impaired intestinal absorption, decreased storage capacity of liver, damage to the renal epithelial cells due to alcohol, leading to increased loss from the kidneys, and excessive loss associated with medical conditions.[2],[3] Furthermore, alcohol decreases the absorption of colonic bacterial thiamine, reduces the enzymatic activity of thiamine pyrophosphokinase, and thereby, reducing the amount of available thiamine pyrophosphate.[4] Since facilitated diffusion of thiamine into cells is dependent on a concentration gradient, reduced thiamine pyrophosphokinase activity further reduces thiamine uptake into cells.[4] Impaired utilization of thiamine is seen in certain conditions (e.g., hypomagnesemia) which are common in alcohol use disorder.[2],[3],[4] This narrative review discusses the neuropsychiatric syndromes associated with thiamine deficiency in the context of alcohol use disorder, and the treatment regimens advocated for these conditions. A PubMed search supplemented with manual search was used to identify neuropsychiatric syndromes related to thiamine deficiency in alcohol use disorder patients. Neuropsychiatric Syndromes Associated With Thiamine Deficiency WernickeâÂÂKorsakoff syndromeWernicke encephalopathy is associated with chronic alcohol use, and if not identified and treated early, could lead to permanent brain damage characterized by an amnestic syndrome known as Korsakoff syndrome. Inappropriate treatment of Wernicke encephalopathy with lower doses of thiamine can lead to high mortality rates (~20%) and Korsakoff syndrome in ~ 80% of patients (ranges from 56% to 84%).[5],[6] The classic triad of Wernicke includes oculomotor abnormalities, cerebellar dysfunction, and confusion. Wernicke lesions are found in 12.5% of brain samples of patients with alcohol dependence.[7] However, only 20%âÂÂ30% of them had a clinical diagnosis of Wernicke encephalopathy antemortem. It has been found that many patients develop WernickeâÂÂKorsakoff syndrome (WKS) following repeated subclinical episodes of thiamine deficiency.[7] In an autopsy report of 97 chronic alcohol users, only16% had all the three âÂÂclassical signs,â 29% had two signs, 37% presented with one sign, and 19% had none.[8] Mental status changes are the most prevalent sign (seen in 82% of the cases), followed by eye signs (in 29%) and ataxia (23%).[8] WKS should be suspected in persons with a history of alcohol use and presenting with signs of ophthalmoplegia, ataxia, acute confusion, memory disturbance, unexplained hypotension, hypothermia, coma, or unconsciousness.[9] Operational criteria for the diagnosis of Wernicke encephalopathy have been proposed by Caine et al.[10] that requires two out of four features, i.e., (a) dietary deficiency (signs such as cheilitis, glossitis, and bleeding gums), (b) oculomotor abnormalities (nystagmus, opthalmoplegia, and diplopia), (c) cerebellar dysfunction (gait ataxia, nystagmus), and (d) either altered mental state (confusion) or mild memory impairment.As it is very difficult to clinically distinguish Wernicke encephalopathy from other associated conditions such as delirium tremens, hepatic encephalopathy, or head injury, it is prudent to have a lower threshold to diagnose this if any of the clinical signs is seen. Magnetic resonance imaging (MRI) brain scan during Wernicke encephalopathy shows mammillary body atrophy and enlarged third ventricle, lesions in the medial portions of thalami and mid brain and can be used to aid diagnosis.[11],[12] However, most clinical situations warrant treatment without waiting for neuroimaging report. The treatment suggestions in the guidelines vary widely. Furthermore, hardly any evidence-based recommendations exist on a more general use of thiamine as a preventative intervention in individuals with alcohol use disorder.[13] There are very few studies that have evaluated the dose and duration of thiamine for WKS, but higher doses may result in a greater response.[6],[14] With thiamine administration rapid improvement is seen in eye movement abnormalities (improve within days or weeks) and ataxia (may take months to recover), but the effects on memory, in particular, are unclear.[4],[14] Severe memory impairment is the core feature of Korsakoff syndrome. Initial stages of the disease can present with confabulation, executive dysfunction, flattened affect, apathy, and poor insight.[15] Both the episodic and semantic memory are affected, whereas, procedural memory remains intact.[15]Thomson et al.[6] suggested the following should be treated with thiamine as they are at high risk for developing WKS. (1) all patients with any evidence of chronic alcohol misuse and any of the following. Acute confusion, decreased conscious level, ataxia, ophthalmoplegia, memory disturbance, and hypothermia with hypotension. (2) patients with delirium tremens may often also have Wernicke encephalopathy, therefore, all of these patients should be presumed to have Wernicke encephalopathy and treated, preferably as inpatients. And (3) all hypoglycemic patients (who are treated with intravenous glucose) with evidence of chronic alcohol ingestion must be given intravenous thiamine immediately because of the risk of acutely precipitating Wernicke encephalopathy.Alcoholic cerebellar syndromeChronic alcohol use is associated with the degeneration of anterior superior vermis, leading to a clinical syndrome characterized by the subacute or chronic onset of gait ataxia and incoordination in legs, with relative sparing of upper limbs, speech, and oculomotor movements.[16] In severe cases, truncal ataxia, mild dysarthria, and incoordination of the upper limb is also found along with gait ataxia. Thiamine deficiency is considered to be the etiological factor,[17],[18] although direct toxic effects of alcohol may also contribute to this syndrome. One-third of patients with chronic use of alcohol have evidence of alcoholic cerebellar degeneration. However, population-based studies estimate prevalence to be 14.6%.[19] The effect of alcohol on the cerebellum is graded with the most severe deficits occurring in alcohol users with the longest duration and highest severity of use. The diagnosis of cerebellar degeneration is largely clinical. MRI can be used to evaluate for vermian atrophy but is unnecessary.[20] Anterior portions of vermis are affected early, with involvement of posterior vermis and adjacent lateral hemispheres occurring late in the course could be used to differentiate alcoholic cerebellar degeneration from other conditions that cause more diffuse involvement.[21] The severity of cerebellar syndrome is more in the presence of WKS, thus could be related to thiamine deficiency.[22],[23] Therefore, this has been considered as a cerebellar presentation of WKS and should be treated in a similar way.[16] There are anecdotal evidence to suggest improvement in cerebellar syndrome with high-dose thiamine.[24]Alcoholic peripheral neuropathyPeripheral neuropathy is common in alcohol use disorder and is seen in 44% of the users.[25] It has been associated predominantly with thiamine deficiency. However, deficiency of other B vitamins (pyridoxine and cobalamin) and direct toxic effect of alcohol is also implicated.[26] Clinically, onset of symptoms is gradual with the involvement of both sensory and motor fibers and occasionally autonomic fibers. Neuropathy can affect both small and large peripheral nerve fibers, leading to different clinical manifestations. Thiamine deficiency-related neuropathy affects larger fiber types, which results in motor deficits and sensory ataxia. On examination, large fiber involvement is manifested by distal limb muscle weakness and loss of proprioception and vibratory sensation. Together, these can contribute to the gait unsteadiness seen in chronic alcohol users by creating a superimposed steppage gait and reduced proprioceptive input back to the movement control loops in the central nervous system. The most common presentations include painful sensations in both lower limbs, sometimes with burning sensation or numbness, which are early symptoms. Typically, there is a loss of vibration sensation in distal lower limbs. Later symptoms include loss of proprioception, gait disturbance, and loss of reflexes. Most advanced findings include weakness and muscle atrophy.[20] Progression is very gradual over months and involvement of upper limbs may occur late in the course. Diagnosis begins with laboratory evaluation to exclude other causes of distal, sensorimotor neuropathy including hemoglobin A1c, liver function tests, and complete blood count to evaluate for red blood cell macrocytosis. Cerebrospinal fluid studies may show increased protein levels but should otherwise be normal in cases of alcohol neuropathy and are not recommended in routine evaluation. Electromyography and nerve conduction studies can be used to distinguish whether the neuropathy is axonal or demyelinating and whether it is motor, sensory, or mixed type. Alcoholic neuropathy shows reduced distal, sensory amplitudes, and to a lesser extent, reduced motor amplitudes on nerve conduction studies.[20] Abstinence and vitamin supplementation including thiamine are the treatments advocated for this condition.[25] In mild-to-moderate cases, near-complete improvement can be achieved.[20] Randomized controlled trials have showed a significant improvement in alcoholic polyneuropathy with thiamine treatment.[27],[28]MarchiafavaâÂÂBignami syndromeThis is a rare but fatal condition seen in chronic alcohol users that is characterized by progressive demyelination and necrosis of the corpus callosum. The association of this syndrome with thiamine deficiency is not very clear, and direct toxic effects of alcohol are also suggested.[29] The clinical syndrome is variable and presentation can be acute, subacute, or chronic. In acute forms, it is predominantly characterized by the altered mental state such as delirium, stupor, or coma.[30] Other clinical features in neuroimaging confirmed MarchiafavaâÂÂBignami syndrome (MBS) cases include impaired gait, dysarthria, mutism, signs of split-brain syndrome, pyramidal tract signs, primitive reflexes, rigidity, incontinence, gaze palsy, diplopia, and sensory symptoms.[30] Neuropsychiatric manifestations are common and include psychotic symptoms, depression, apathy, aggressive behavior, and sometimes dementia.[29] MRI scan shows lesions of the corpus callosum, particularly splenium. Treatment for this condition is mostly supportive and use of nutritional supplements and steroids. However, there are several reports of improvement of this syndrome with thiamine at variable doses including reports of beneficial effects with high-dose strategy.[29],[30],[31] Early initiation of thiamine, preferably within 2 weeks of the onset of symptoms is associated with a better outcome. Therefore, high-dose thiamine should be administered to all suspected cases of MBS. Laboratory Diagnosis of Thiamine Deficiency Estimation of thiamine and thiamine pyrophosphate levels may confirm the diagnosis of deficiency. Levels of thiamine in the blood are not reliable indicators of thiamine status. Low erythrocyte transketolase activity is also helpful.[32],[33] Transketolase concentrations of <120 nmol/L have also been used to indicate deficiency, while concentrations of 120âÂÂ150 nmol/L suggest marginal thiamine status.[1] However, these tests are not routinely performed as it is time consuming, expensive, and may not be readily available.[34] The ETKA assay is a functional test rather than a direct measurement of thiamin status and therefore may be influenced by factors other than thiamine deficiency such as diabetes mellitus and polyneuritis.[1] Hence, treatment should be initiated in the absence of laboratory confirmation of thiamine deficiency. Furthermore, treatment should not be delayed if tests are ordered, but the results are awaited. Electroencephalographic abnormalities in thiamine deficiency states range from diffuse mild-to-moderate slow waves and are not a good diagnostic option, as the prevalence of abnormalities among patients is inconsistent.[35]Surrogate markers, which reflect chronic alcohol use and nutritional deficiency other than thiamine, may be helpful in identifying at-risk patients. This includes gamma glutamate transferase, aspartate aminotransferase. Alanine transaminase ratio >2:1, and increased mean corpuscular volume.[36] They are useful when a reliable history of alcohol use is not readily available, specifically in emergency departments when treatment needs to be started immediately to avoid long-term consequences. Thiamine Replacement Therapy Oral versus parenteral thiamineIntestinal absorption of thiamine depends on active transport through thiamine transporter 1 and 2, which follow saturation kinetics.[1] Therefore, the rate and amount of absorption of thiamine in healthy individuals is limited. In healthy volunteers, a 10 mg dose results in maximal absorption of thiamine, and any doses higher than this do not increase thiamine levels. Therefore, the maximum amount of thiamine absorbed from 10 mg or higher dose is between 4.3 and 5.6 mg.[37] However, it has been suggested that, although thiamine transport occurs through the energy-requiring, sodium-dependent active process at physiologic concentrations, at higher supraphysiologic concentrations thiamine uptake is mostly a passive process.[38] Smithline et al. Have demonstrated that it is possible to achieve higher serum thiamine levels with oral doses up to 1500 mg.[39]In chronic alcohol users, intestinal absorption is impaired. Hence, absorption rates are expected to be much lower. It is approximately 30% of that seen in healthy individuals, i.e., 1.5 mg of thiamine is absorbed from 10 mg oral thiamine.[3] In those consuming alcohol and have poor nutrition, not more than 0.8 mg of thiamine is absorbed.[2],[3],[6] The daily thiamine requirement is 1âÂÂ1.6 mg/day, which may be more in alcohol-dependent patients at risk for Wernicke encephalopathy.[1] It is highly likely that oral supplementation with thiamine will be inadequate in alcohol-dependent individuals who continue to drink. Therefore, parenteral thiamine is preferred for supplementation in deficiency states associated with chronic alcohol use. Therapy involving parenteral thiamine is considered safe except for occasional circumstances of allergic reactions involving pruritus and local irritation.There is a small, but definite risk of anaphylaxis with parenteral thiamine, specifically with intravenous administration (1/250,000 intravenous injections).[40] Diluting thiamine in 50âÂÂ100 mg normal saline for infusion may reduce the risk. However, parenteral thiamine should always be administered under observation with the necessary facilities for resuscitation.A further important issue involves the timing of administration of thiamine relative to the course of alcohol abuse or dependence. Administration of thiamine treatment to patients experiencing alcohol withdrawal may also be influenced by other factors such as magnesium depletion, N-methyl-D-aspartate (NMDA) receptor upregulation, or liver impairment, all of which may alter thiamine metabolism and utilization.[6],[14]Thiamine or other preparations (e.g., benfotiamine)The thiamine transporters limit the rate of absorption of orally administered thiamine. Allithiamines (e.g., benfotiamine) are the lipid-soluble thiamine derivatives that are absorbed better, result in higher thiamine levels, and are retained longer in the body.[41] The thiamine levels with orally administered benfotiamine are much higher than oral thiamine and almost equals to intravenous thiamine given at the same dosage.[42]Benfotiamine has other beneficial effects including inhibition of production of advanced glycation end products, thus protecting against diabetic vascular complications.[41] It also modulates nuclear transcription factor úB (NK-úB), vascular endothelial growth factor receptor 2, glycogen synthase kinase 3 ò, etc., that play a role in cell repair and survival.[41] Benfotiamine has been found to be effective for the treatment of alcoholic peripheral neuropathy.[27]Dosing of thiamineAs the prevalence of thiamine deficiency is very common in chronic alcohol users, the requirement of thiamine increases in active drinkers and it is difficult to rapidly determine thiamine levels using laboratory tests, it is prudent that all patients irrespective of nutritional status should be administered parenteral thiamine. The dose should be 100 mg thiamine daily for 3âÂÂ5 days during inpatient treatment. Commonly, multivitamin injections are added to intravenous infusions. Patients at risk for thiamine deficiency should receive 250 mg of thiamine daily intramuscularly for 3âÂÂ5 days, followed by oral thiamine 100 mg daily.[6]Thiamine plasma levels reduce to 20% of peak value after approximately 2 h of parenteral administration, thus reducing the effective âÂÂwindow periodâ for passive diffusion to the central nervous system.[6] Therefore, in thiamine deficient individuals with features of Wernicke encephalopathy should receive thiamine thrice daily.High-dose parenteral thiamine administered thrice daily has been advocated in patients at risk for Wernicke encephalopathy.[43] The Royal College of Physicians guideline recommends that patients with suspected Wernicke encephalopathy should receive 500 mg thiamine diluted in 50âÂÂ100 ml of normal saline infusion over 30 min three times daily for 2âÂÂ3 days and sometimes for longer periods.[13] If there are persistent symptoms such as confusion, cerebellar symptoms, or memory impairment, this regimen can be continued until the symptoms improve. If symptoms improve, oral thiamine 100 mg thrice daily can be continued for prolonged periods.[6],[40] A similar treatment regimen is advocated for alcoholic cerebellar degeneration as well. Doses more than 500 mg intramuscular or intravenous three times a day for 3âÂÂ5 days, followed by 250 mg once daily for a further 3âÂÂ5 days is also recommended by some guidelines (e.g., British Association for Psychopharmacology).[44]Other effects of thiamineThere are some data to suggest that thiamine deficiency can modulate alcohol consumption and may result in pathological drinking. Benfotiamine 600 mg/day as compared to placebo for 6 months was well tolerated and found to decrease psychiatric distress in males and reduce alcohol consumption in females with severe alcohol dependence.[45],[46] Other Factors During Thiamine Therapy Correction of hypomagnesemiaMagnesium is a cofactor for many thiamine-dependent enzymes in carbohydrate metabolism. Patients may fail to respond to thiamine supplementation in the presence of hypomagnesemia.[47] Magnesium deficiency is common in chronic alcohol users and is seen in 30% of individuals.[48],[49] It can occur because of increased renal excretion of magnesium, poor intake, decreased absorption because of Vitamin D deficiency, the formation of undissociated magnesium soaps with free fatty acids.[48],[49]The usual adult dose is 35âÂÂ50 mmol of magnesium sulfate added to 1 L isotonic (saline) given over 12âÂÂ24 h.[6] The dose has to be titrated against plasma magnesium levels. It is recommended to reduce the dose in renal failure. Contraindications include patients with documented hypersensitivity and those with heart block, Addison's disease, myocardial damage, severe hepatitis, or hypophosphatemia. Do not administer intravenous magnesium unless hypomagnesemia is confirmed.[6]Other B-complex vitaminsMost patients with deficiency of thiamine will also have reduced levels of other B vitamins including niacin, pyridoxine, and cobalamin that require replenishment. For patients admitted to the intensive care unit with symptoms that may mimic or mask Wernicke encephalopathy, based on the published literature, routine supplementation during the 1st day of admission includes 200âÂÂ500 mg intravenous thiamine every 8 h, 64 mg/kg magnesium sulfate (âÂÂ4âÂÂ5 g for most adult patients), and 400âÂÂ1000 üg intravenous folate.[50] If alcoholic ketoacidosis is suspected, dextrose-containing fluids are recommended over normal saline.[50] Precautions to be Taken When Administering Parenteral Thiamine It is recommended to monitor for anaphylaxis and has appropriate facilities for resuscitation and for treating anaphylaxis readily available including adrenaline and corticosteroids. Anaphylaxis has been reported at the rate of approximately 4/1 million pairs of ampoules of Pabrinex (a pair of high potency vitamins available in the UK containing 500 mg of thiamine (1:250,000 I/V administrations).[40] Intramuscular thiamine is reported to have a lower incidence of anaphylactic reactions than intravenous administration.[40] The reaction has been attributed to nonspecific histamine release.[51] Administer intravenous thiamine slowly, preferably by slow infusion in 100 ml normal saline over 15âÂÂ30 min. Conclusions Risk factors for thiamine deficiency should be assessed in chronic alcohol users. A high index of suspicion and a lower threshold to diagnose thiamine deficiency states including Wernicke encephalopathy is needed. Several other presentations such as cerebellar syndrome, MBS, polyneuropathy, and delirium tremens could be related to thiamine deficiency and should be treated with protocols similar to Wernicke encephalopathy. High-dose thiamine is recommended for the treatment of suspected Wernicke encephalopathy and related conditions [Figure 1]. However, evidence in terms of randomized controlled trials is lacking, and the recommendations are based on small studies and anecdotal reports. Nevertheless, as all these conditions respond to thiamine supplementation, it is possible that these have overlapping pathophysiology and are better considered as Wernicke encephalopathy spectrum disorders.Figure 1. Thiamine recommendations for patients with alcohol use disorder. AHistory of alcohol use, but no clinical features of WE. BNo clinical features of WE, but with risk factors such as complicated withdrawal (delirium, seizures). CClinical features of WE (ataxia, opthalmoplegia, global confusion)Click here to viewFinancial support and sponsorshipNil.Conflicts of interestThere are no conflicts of interest. References 1.Frank LL. Thiamin in clinical practice. JPEN J Parenter Enteral Nutr 2015;39:503-20. 2.Thomson AD, Marshall EJ. The natural history and pathophysiology of Wernicke's Encephalopathy and Korsakoff's Psychosis. Alcohol Alcohol 2006;41:151-8. 3.Thomson AD, Guerrini I, Marshall EJ. Wernicke's encephalopathy. Role of thiamine. Pract Gastroenterol 2009;33:21-30. 4.Isenberg-Grzeda E, Kutner HE, Nicolson SE. Wernicke-Korsakoff-syndrome. Under-recognized and under-treated. Psychosomatics 2012;53:507-16. 5.Wood B, Currie J, Breen K. Wernicke's encephalopathy in a metropolitan hospital. A prospective study of incidence, characteristics and outcome. Med J Aust 1986;144:12-6. 6.Thomson AD, Cook CC, Touquet R, Henry JA, Royal College of Physicians, London. The Royal College of Physicians report on alcohol. Guidelines for managing Wernicke's encephalopathy in the accident and Emergency Department. Alcohol Alcohol 2002;37:513-21. 7.Harper C. Thiamine (vitamin B1) deficiency and associated brain damage is still common throughout the world and prevention is simple and safe!. Eur J Neurol 2006;13:1078-82. 8.Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex. A retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986;49:341-5. 9.Cook CC. Prevention and treatment of Wernicke-Korsakoff syndrome. Alcohol Alcohol 2000;35:19-20. 10.Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics. Identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 1997;62:51-60. 11.Sullivan EV, Pfefferbaum A. Neuroimaging of the Wernicke-Korsakoff syndrome. Alcohol Alcohol 2009;44:155-65. 12.Jung YC, Chanraud S, Sullivan EV. Neuroimaging of Wernicke's encephalopathy and Korsakoff's syndrome. Neuropsychol Rev 2012;22:170-80. 13.Pruckner N, Baumgartner J, Hinterbuchinger B, Glahn A, Vyssoki S, Vyssoki B. Thiamine substitution in alcohol use disorder. A narrative review of medical guidelines. Eur Addict Res 2019;25:103-10. 14.Day E, Bentham PW, Callaghan R, Kuruvilla T, George S. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev 2013;7:CD004033. Doi. 10.1002/14651858.CD004033.pub3. 15.Arts NJ, Walvoort SJ, Kessels RP. Korsakoff's syndrome. A critical review. Neuropsychiatr Dis Treat 2017;13:2875-90. 16.Laureno R. Nutritional cerebellar degeneration, with comments on its relationship to Wernicke disease and alcoholism. Handb Clin Neurol 2012;103:175-87. 17.Maschke M, Weber J, Bonnet U, Dimitrova A, Bohrenkämper J, Sturm S, et al. Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI. J Neurol 2005;252:704-11. 18.Mulholland PJ, Self RL, Stepanyan TD, Little HJ, Littleton JM, Prendergast MA. Thiamine deficiency in the pathogenesis of chronic ethanol-associated cerebellar damage in vitro. Neuroscience 2005;135:1129-39. 19.Del Brutto OH, Mera RM, Sullivan LJ, Zambrano M, King NR. Population-based study of alcoholic cerebellar degeneration. The Atahualpa Project. J Neurol Sci 2016;367:356-60. 20.Hammoud N, Jimenez-Shahed J. Chronic neurologic effects of alcohol. Clin Liver Dis 2019;23:141-55. 21.Lee JH, Heo SH, Chang DI. Early-stage alcoholic cerebellar degeneration. Diagnostic imaging clues. J Korean Med Sci 2015;30:1539. 22.Phillips SC, Harper CG, Kril JJ. The contribution of Wernicke's encephalopathy to alcohol-related cerebellar damage. Drug Alcohol Rev 1990;9:53-60. 23.Baker KG, Harding AJ, Halliday GM, Kril JJ, Harper CG. Neuronal loss in functional zones of the cerebellum of chronic alcoholics with and without Wernicke's encephalopathy. Neuroscience 1999;91:429-38. 24.Graham JR, Woodhouse D, Read FH. Massive thiamine dosage in an alcoholic with cerebellar cortical degeneration. Lancet 1971;2:107. 25.Julian T, Glascow N, Syeed R, Zis P. Alcohol-related peripheral neuropathy. A systematic review and meta-analysis. J Neurol 2018;22:1-3. 26.Chopra K, Tiwari V. Alcoholic neuropathy. Possible mechanisms and future treatment possibilities. Br J Clin Pharmacol 2012;73:348-62. 27.Woelk H, Lehrl S, Bitsch R, Köpcke W. Benfotiamine in treatment of alcoholic polyneuropathy. An 8-week randomized controlled study (BAP I Study). Alcohol Alcohol 1998;33:631-8. 28.Peters TJ, Kotowicz J, Nyka W, Kozubski W, Kuznetsov V, Vanderbist F, et al. Treatment of alcoholic polyneuropathy with vitamin B complex. A randomised controlled trial. Alcohol Alcohol 2006;41:636-42. 29.Fernandes LM, Bezerra FR, Monteiro MC, Silva ML, de Oliveira FR, Lima RR, et al. Thiamine deficiency, oxidative metabolic pathways and ethanol-induced neurotoxicity. How poor nutrition contributes to the alcoholic syndrome, as Marchiafava-Bignami disease. Eur J Clin Nutr 2017;71:580-6. 30.Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of Marchiafava-Bignami disease. A review of CT/MRI confirmed cases. J Neurol Neurosurg Psychiatry 2014;85:168-73. 31.Nemlekar SS, Mehta RY, Dave KR, Shah ND. Marchiafava. Bignami disease treated with parenteral thiamine. Indian J Psychol Med 2016;38:147-9. [Full text] 32.Brin M. Erythrocyte transketolase in early thiamine deficiency. Ann N Y Acad Sci 1962;98:528-41. 33.Dreyfus PM. Clinical application of blood transketolase determinations. N Engl J Med 1962;267:596-8. 34.Edwards KA, Tu-Maung N, Cheng K, Wang B, Baeumner AJ, Kraft CE. Thiamine assays â Advances, challenges, and caveats. ChemistryOpen 2017;6:178-91. 35.Chandrakumar A, Bhardwaj A, 't Jong GW. Review of thiamine deficiency disorders. Wernicke encephalopathy and Korsakoff psychosis. J Basic Clin Physiol Pharmacol 2018;30:153-62. 36.Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol 2014;20:11684-99. 37.Thomson AD, Leevy CM. Observations on the mechanism of thiamine hydrochloride absorption in man. Clin Sci 1972;43:153-63. 38.Hoyumpa AM Jr., Strickland R, Sheehan JJ, Yarborough G, Nichols S. Dual system of intestinal thiamine transport in humans. J Lab Clin Med 1982;99:701-8. 39.Smithline HA, Donnino M, Greenblatt DJ. Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects. BMC Clin Pharmacol 2012;12:4. 40.Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J 2014;44:911-5. 41.Raj V, Ojha S, Howarth FC, Belur PD, Subramanya SB. Therapeutic potential of benfotiamine and its molecular targets. Eur Rev Med Pharmacol Sci 2018;22:3261-73. 42.Xie F, Cheng Z, Li S, Liu X, Guo X, Yu P, et al. Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride. J Clin Pharmacol 2014;54:688-95. 43.Cook CC, Hallwood PM, Thomson AD. B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol 1998;33:317-36. 44.Lingford-Hughes AR, Welch S, Peters L, Nutt DJ, British Association for Psychopharmacology, Expert Reviewers Group. BAP updated guidelines. Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity. Recommendations from BAP. J Psychopharmacol 2012;26:899-952. 45.Manzardo AM, He J, Poje A, Penick EC, Campbell J, Butler MG. Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence. Drug Alcohol Depend 2013;133:562-70. 46.Manzardo AM, Pendleton T, Poje A, Penick EC, Butler MG. Change in psychiatric symptomatology after benfotiamine treatment in males is related to lifetime alcoholism severity. Drug Alcohol Depend 2015;152:257-63. 47.Dingwall KM, Delima JF, Gent D, Batey RG. Hypomagnesaemia and its potential impact on thiamine utilisation in patients with alcohol misuse at the Alice Springs Hospital. Drug Alcohol Rev 2015;34:323-8. 48.Flink EB. Magnesium deficiency in alcoholism. Alcohol Clin Exp Res 1986;10:590-4. 49.Grochowski C, Blicharska E, Baj J, Mierzwià Âska A, Brzozowska K, Forma A, et al. Serum iron, magnesium, copper, and manganese levels in alcoholism. A systematic review. Molecules 2019;24:E1361. 50.Flannery AH, Adkins DA, Cook AM. Unpeeling the evidence for the banana bag. Evidence-based recommendations for the management of alcohol-associated vitamin and electrolyte deficiencies in the ICU. Crit Care Med 2016;44:1545-52. 51.Lagunoff D, Martin TW, Read G. Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol 1983;23:331-51. Correspondence Address:Samir Kumar PraharajDepartment of Psychiatry, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka IndiaSource of Support. None, Conflict of Interest. NoneDOI. 10.4103/psychiatry.IndianJPsychiatry_440_20 Figures [Figure 1]. Kamagra 100mgNSW will take its first steps towards reopening as the State passes the 70 per cent double vaccination target.With the first vaccination milestone being reached, the NSW Government is also easing a number of restrictions as part of the Reopening NSW roadmap, which will kamagra 100mg allow fully vaccinated adults to enjoy more freedoms from next Monday, October 11.The changes to the 70 per cent roadmap will allow up to 10 visitors (not counting children 12 and under) to a home (previously five), lift the cap on outdoor gatherings to 30 people (previously 20), and increase the cap for weddings and funerals to 100 people (previously 50). Indoor pools will also be re-opened for swimming lessons, squad training, lap swimming, and rehab activities. On the Monday after the State clears the 80 per cent double vaccination hurdle further restrictions will be relaxed, with people able to have up to 20 visitors (excluding children 12 and under) to a home (previously 10), and up to 50 people will kamagra 100mg be allowed to gather outdoors (previously 20). Up to 3,000 people will be allowed to attend controlled and ticketed outdoor events (previously 500), nightclubs will be permitted to reopen for seated drinking only (no dancing), and masks will no longer be required in office buildings. All roadmap freedoms at 70 and 80 per cent will continue to be for fully vaccinated people only.All school students will also now return to on site learning with a range of erectile dysfunction treatment-safe measures in place by October kamagra 100mg 25, with the second and third stages of the return to school plan now combined. Kindergarten, Year 1 and Year 12 students will still return to face-to-face learning on October 18, with all other years now returning one week later on October 25. Premier Dominic Perrottet said the common-sense kamagra 100mg changes would help life return to normal as soon as possible. ÃÂÂVaccinations are the key to life returning to normal and the changes today will help family and friends reconnect, get kids back to school and get businesses back up and running sooner,â Mr Perrottet said.âÂÂNSW is putting in the hard yards and itâÂÂs important people continue to turn out in droves to be vaccinated.âÂÂDeputy Premier Paul Toole said workers in regional areas who have received one vaccination dose will be permitted to return to their workplace from October 11 and will be given a grace period until November 1 to receive their second dose. Regional areas are those outside kamagra 100mg Greater Sydney, the Blue Mountains, Wollongong, Shellharbour and the Central Coast. ÃÂÂThis move ensures we get businesses in the regions re-open and local economies buzzing again. It's about ensuring we make this kamagra 100mg a roadmap that works for everyone,â Mr Toole said.Minister for Jobs, Investment, Tourism and Western Sydney Stuart Ayres said these changes would help get more people back into work, especially in Western Sydney.âÂÂWeâÂÂre on the road back to normal and most importantly reaching these vaccination targets means people can reunite with family and friends, celebrate key moments in their lives and businesses can open their doors and get back to work in a safe way,â Mr Ayres said. Health Minister Brad Hazzard said NSW residents 12-years-old and over have led the charge to get vaccinated and ensure NSW is among the safest places in the world.âÂÂGetting to 70 per cent double dose is a badge of honour for every fully vaccinated NSW citizen to wear proudly but we can do so much more and 90 per cent is within our grasp,â Mr Hazzard said.Minister for Education and Early Childhood Learning Sarah Mitchell said schools were ready to welcome students back.âÂÂThe return remains safe and sensible with enough time for schools to prepare for a faster return of students over two weeks instead of three,â Ms Mitchell said.âÂÂPrincipals have received detailed guidance and checklists of everything required to ensure erectile dysfunction treatment-safe settings in their school. Parents and carers will also kamagra 100mg receive a detailed guide today and more specific information from their school in the coming days.âÂÂIf you are not booked in for a erectile dysfunction treatment, please book an appointment as soon possible.Note also that as the stay-at-home orders will be lifted next Monday and replaced by the roadmap settings, the list of Local Government Areas of concern will cease to exist. For the latest information visit the erectile dysfunction treatment pages on nsw.gov.au.New public health advice sets out how NSW will continue to tackle erectile dysfunction treatment as the state begins to reopen when it reaches the 70 per cent double dose vaccination target. Health Minister Brad Hazzard said while high kamagra 100mg vaccination rates were the key factor in the roadmap to recovery, erectile dysfunction treatment will continue to circulate in the community. ÃÂÂNSW is leading the nation in so many ways with its kamagra response but particularly in its vaccination efforts. I urge those who are yet to get vaccinated kamagra 100mg to do so quickly to protect yourself, your loved ones and the community,â Mr Hazzard said. ÃÂÂWe are closing-in on the 70 per cent double dose mark and when we achieve it there will be significant changes to our public health advice and the key difference will be how that advice is applied to people who are vaccinated and to those who are not. ÃÂÂVaccination will provide greater freedoms as our society kamagra 100mg opens up and it reduces the risk of you spreading the kamagra to someone vulnerable, which could cost them their life. ÃÂÂDespite the ongoing challenges that will continue to be posed by erectile dysfunction treatment, we have the opportunity to lead the world which is why it is vital everyone is vaccinated and follows the updated public health advice that will be in place from 11 October.âÂÂSome of the key public health advice for the general community will be. Everyone, vaccinated and not vaccinated, is urged to get tested if you have any symptoms of erectile dysfunction treatment and immediately self-isolate until a negative result is received.Whether you are vaccinated or not kamagra 100mg vaccinated, if you test positive for erectile dysfunction treatment you must self-isolate for 14 days. Close contacts in the community will include household members of positive cases and close social contacts of positive cases, such as partners and friends, who you spent time in close proximity with, even if fully vaccinated. Anyone may also be assessed as kamagra 100mg a being a close contact following a risk assessment, including at workplaces, high-risk settings, such as healthcare and aged care, and other specific settings such as schools and child care centres, or where an outbreak has been identified. If you are a close contact of a positive case and vaccinated, you must get tested and self-isolate for seven days. On day six kamagra 100mg after exposure, you must get tested again. If a negative result is received and you are well, you can end isolation after day seven. For the following seven days you must work from home where practicable, not attend hospitality settings, and not attend a high-risk kamagra 100mg settings even if it is your place of work. If you are a close contact of a positive case and not vaccinated you must get tested and immediately self-isolate for 14 days. On day kamagra 100mg 12, you should get tested again. If a negative result is received, you can end isolation after day 14.The Service NSW QR code check-in system will remain in place in the general community. This system will be used to notify people kamagra 100mg who were in the same venue as a positive case. People will be asked to monitor for symptoms and get tested if they become unwell. Other settings, including schools, workplaces and high-risk settings, such as healthcare and aged care, will kamagra 100mg have specific risk assessment approaches. People aged 16 years and over will only be allowed entry into some venues or settings if fully vaccinated, along with people with exemptions. In some venues, children under 16 will have to be accompanied kamagra 100mg by a fully vaccinated member of their household to enter. This includes hospitality venues, non-critical retail stores, personal services, sporting, recreation and entertainment facilities and events. Critical retail such as supermarkets and pharmacies will still be accessible to kamagra 100mg those not fully vaccinated. There are several options to show proof of erectile dysfunction treatment vaccination or exemption. Some of the key public health advice kamagra 100mg for the business community will be. If a staff member tests positive, whether they are vaccinated or not vaccinated, they must self-isolate for 14 days and follow the advice from NSW Health. Businesses will refer to their erectile dysfunction treatment Safety Plan and risk assessment approach for further instructions on notifying other staff.Businesses must inform NSW Health if three or kamagra 100mg more employees test positive for erectile dysfunction treatment in a seven-day period.NSW Health guidelines will enable businesses to assess workplace risk if a erectile dysfunction treatment case is identified and confirm actions to be taken.Businesses can reduce the risk of closure or staff going into isolation by implementing rigorous erectile dysfunction treatment Safety Plans. Other proactive steps businesses can take include ensuring staff are vaccinated and implementing regular onsite testing programs for workers. With respect to vaccination compliance and obligations:Businesses will be kamagra 100mg responsible for taking reasonable measures to stop unvaccinated people entering premises. For example, having prominent signs stating requirements, Service NSW QR codes, staff checking vaccination status upon entry and only accepting valid forms of evidence of vaccination. Authorised officers will monitor businesses kamagra 100mg re-opening, particularly those that have vaccination requirements, for example hospitality, retail, gyms, and personal services (e.g. Hair, beauty). Penalties may apply for kamagra 100mg individuals and businesses who donâÂÂt comply. On the spot fines of $1,000 may apply to individuals for not complying, or for using fraudulent evidence of vaccination or check-in. On the spot fines of $5,000 may apply to businesses for not complying with the Public Health Order vaccination kamagra 100mg requirements. Further penalties may apply for significant breaches.NSW Chief Health Officer Dr Kerry Chant said it is important to note that the new advice may be updated by NSW Health as case numbers and evidence changes.âÂÂWe will continue to do what we have done throughout this kamagra, which is to regularly update our advice, informed by experience, feedback, and emerging evidence. It is only in partnership that we can reopen in a safe way.âÂÂVisit nsw.gov.au for the latest information. NSW will take its first steps towards reopening as the State passes the 70 per cent double vaccination target.With the first vaccination milestone being reached, the NSW Government is also easing a number of restrictions as part of the Reopening NSW roadmap, which will allow fully vaccinated adults to enjoy more freedoms from next Monday, October 11.The changes to the 70 per cent roadmap will allow up to 10 visitors https://actio-rae.de/online-doctor-viagra/ (not counting children 12 and under) to a home (previously five), lift the cap on outdoor gatherings to kamagra online without prescription 30 people (previously 20), and increase the cap for weddings and funerals to 100 people (previously 50). Indoor pools will also be re-opened for swimming lessons, squad training, lap swimming, and rehab activities. On the Monday after the State clears the 80 per cent double vaccination hurdle further restrictions will be relaxed, with people able to have up to 20 visitors (excluding children 12 and under) to a home (previously 10), and up to 50 people will kamagra online without prescription be allowed to gather outdoors (previously 20). Up to 3,000 people will be allowed to attend controlled and ticketed outdoor events (previously 500), nightclubs will be permitted to reopen for seated drinking only (no dancing), and masks will no longer be required in office buildings. All roadmap kamagra online without prescription freedoms at 70 and 80 per cent will continue to be for fully vaccinated people only.All school students will also now return to on site learning with a range of erectile dysfunction treatment-safe measures in place by October 25, with the second and third stages of the return to school plan now combined. Kindergarten, Year 1 and Year 12 students will still return to face-to-face learning on October 18, with all other years now returning one week later on October 25. Premier Dominic Perrottet said the common-sense kamagra online without prescription changes would help life return to normal as soon as possible. ÃÂÂVaccinations are the key to life returning to normal and the changes today will help family and friends reconnect, get kids back to school and get businesses back up and running sooner,â Mr Perrottet said.âÂÂNSW is putting in the hard yards and itâÂÂs important people continue to turn out in droves to be vaccinated.âÂÂDeputy Premier Paul Toole said workers in regional areas who have received one vaccination dose will be permitted to return to their workplace from October 11 and will be given a grace period until November 1 to receive their second dose. Regional areas are kamagra online without prescription those outside Greater Sydney, the Blue Mountains, Wollongong, Shellharbour and the Central Coast. ÃÂÂThis move ensures we get businesses in the regions re-open and local economies buzzing again. It's about ensuring we make this a roadmap that works for everyone,â Mr Toole said.Minister for Jobs, Investment, Tourism and Western Sydney Stuart Ayres said these changes would help get more people kamagra online without prescription back into work, especially in Western Sydney.âÂÂWeâÂÂre on the road back to normal and most importantly reaching these vaccination targets means people can reunite with family and friends, celebrate key moments in their lives and businesses can open their doors and get back to work in a safe way,â Mr Ayres said. Health Minister Brad Hazzard said NSW residents 12-years-old and over have led the charge to get vaccinated and ensure NSW is among the safest places in the world.âÂÂGetting to 70 per cent double dose is a badge of honour for every fully vaccinated NSW citizen to wear proudly but we can do so much more and 90 per cent is within our grasp,â Mr Hazzard said.Minister for Education and Early Childhood Learning Sarah Mitchell said schools were ready to welcome students back.âÂÂThe return remains safe and sensible with enough time for schools to prepare for a faster return of students over two weeks instead of three,â Ms Mitchell said.âÂÂPrincipals have received detailed guidance and checklists of everything required to ensure erectile dysfunction treatment-safe settings in their school. Parents and carers will also receive a detailed guide today and more kamagra online without prescription specific information from their school in the coming days.âÂÂIf you are not booked in for a erectile dysfunction treatment, please book an appointment as soon possible.Note also that as the stay-at-home orders will be lifted next Monday and replaced by the roadmap settings, the list of Local Government Areas of concern will cease to exist. For the latest information visit the erectile dysfunction treatment pages on nsw.gov.au.New public health advice sets out how NSW will continue to tackle erectile dysfunction treatment as the state begins to reopen when it reaches the 70 per cent double dose vaccination target. Health Minister Brad Hazzard said kamagra online without prescription while high vaccination rates were the key factor in the roadmap to recovery, erectile dysfunction treatment will continue to circulate in the community. ÃÂÂNSW is leading the nation in so many ways with its kamagra response but particularly in its vaccination efforts. I urge those who are yet to get vaccinated to do so quickly to protect yourself, your loved ones and the community,â kamagra online without prescription Mr Hazzard said. ÃÂÂWe are closing-in on the 70 per cent double dose mark and when we achieve it there will be significant changes to our public health advice and the key difference will be how that advice is applied to people who are vaccinated and to those who are not. ÃÂÂVaccination will provide greater kamagra online without prescription freedoms as our society opens up and it reduces the risk of you spreading the kamagra to someone vulnerable, which could cost them their life. ÃÂÂDespite the ongoing challenges that will continue to be posed by erectile dysfunction treatment, we have the opportunity to lead the world which is why it is vital everyone is vaccinated and follows the updated public health advice that will be in place from 11 October.âÂÂSome of the key public health advice for the general community will be. Everyone, vaccinated and not vaccinated, is urged to get tested if you have any symptoms of erectile dysfunction treatment and immediately self-isolate until kamagra online without prescription a negative result is received.Whether you are vaccinated or not vaccinated, if you test positive for erectile dysfunction treatment you must self-isolate for 14 days. Close contacts in the community will include household members of positive cases and close social contacts of positive cases, such as partners and friends, who you spent time in close proximity with, even if fully vaccinated. Anyone may also be assessed as a being a close contact following a risk assessment, including at workplaces, high-risk settings, such as healthcare and aged care, and other specific settings such as kamagra online without prescription schools and child care centres, or where an outbreak has been identified. If you are a close contact of a positive case and vaccinated, you must get tested and self-isolate for seven days. On day kamagra online without prescription six after exposure, you must get tested again. If a negative result is received and you are well, you can end isolation after day seven. For the kamagra online without prescription following seven days you must work from home where practicable, not attend hospitality settings, and not attend a high-risk settings even if it is your place of work. If you are a close contact of a positive case and not vaccinated you must get tested and immediately self-isolate for 14 days. On day 12, you kamagra online without prescription should get tested again. If a negative result is received, you can end isolation after day 14.The Service NSW QR code check-in system will remain in place in the general community. This system will be used to notify people who were in the same venue as a positive case kamagra online without prescription. People will be asked to monitor for symptoms and get tested if they become unwell. Other settings, including schools, workplaces and high-risk kamagra online without prescription settings, such as healthcare and aged care, will have specific risk assessment approaches. People aged 16 years and over will only be allowed entry into some venues or settings if fully vaccinated, along with people with exemptions. In some venues, children under 16 will have kamagra online without prescription to be accompanied by a fully vaccinated member of their household to enter. This includes hospitality venues, non-critical retail stores, personal services, sporting, recreation and entertainment facilities and events. Critical retail such as supermarkets and pharmacies will still be accessible kamagra online without prescription to those not fully vaccinated. There are several options to show proof of erectile dysfunction treatment vaccination or exemption. Some of the key public health advice for the business community kamagra online without prescription will be. If a staff member tests positive, whether they are vaccinated or not vaccinated, they must self-isolate for 14 days and follow the advice from NSW Health. Businesses will refer to their erectile dysfunction treatment Safety Plan and risk assessment approach for further instructions on notifying other staff.Businesses must inform NSW Health if three or more employees test positive for erectile dysfunction treatment in a seven-day kamagra online without prescription period.NSW Health guidelines will enable businesses to assess workplace risk if a erectile dysfunction treatment case is identified and confirm actions to be taken.Businesses can reduce the risk of closure or staff going into isolation by implementing rigorous erectile dysfunction treatment Safety Plans. Other proactive steps businesses can take include ensuring staff are vaccinated and implementing regular onsite testing programs for workers. With respect to vaccination compliance and obligations:Businesses will be responsible for taking reasonable kamagra online without prescription measures to stop unvaccinated people entering premises. For example, having prominent signs stating requirements, Service NSW QR codes, staff checking vaccination status upon entry and only accepting valid forms of evidence of vaccination. Authorised officers will monitor businesses re-opening, particularly those that have vaccination requirements, for example hospitality, retail, gyms, and personal services kamagra online without prescription (e.g. Hair, beauty). Penalties may kamagra online without prescription apply for individuals and businesses who donâÂÂt comply. On the spot fines of $1,000 may apply to individuals for not complying, or for using fraudulent evidence of vaccination or check-in. On the spot fines of $5,000 may kamagra online without prescription apply to businesses for not complying with the Public Health Order vaccination requirements. Further penalties may apply for significant breaches.NSW Chief Health Officer Dr Kerry Chant said it is important to note that the new advice may be updated by NSW Health as case numbers and evidence changes.âÂÂWe will continue to do what we have done throughout this kamagra, which is to regularly update our advice, informed by experience, feedback, and emerging evidence. It is only in partnership that we can reopen in a safe way.âÂÂVisit nsw.gov.au for the latest information. Kamagra uk deliveryNCHS Data Propecia 5mg cost Brief kamagra uk delivery No. 286, September 2017PDF Versionpdf icon (374 KB)Anjel Vahratian, Ph.D.Key findingsData from the National Health Interview Survey, 2015Among those aged 40âÂÂ59, perimenopausal women (56.0%) were more likely than postmenopausal (40.5%) and premenopausal (32.5%) women to sleep less than 7 hours, on average, in a 24-hour period.Postmenopausal women aged 40âÂÂ59 were more likely than premenopausal women aged 40âÂÂ59 to have trouble falling asleep (27.1% compared with 16.8%, respectively), and staying asleep (35.9% compared with 23.7%), four times or more in the past week.Postmenopausal women aged 40âÂÂ59 (55.1%) were more likely than premenopausal women aged 40âÂÂ59 (47.0%) to not wake up feeling well rested 4 days or more in the past week.Sleep duration and quality are important contributors to health and wellness. Insufficient sleep kamagra uk delivery is associated with an increased risk for chronic conditions such as cardiovascular disease (1) and diabetes (2). Women may be particularly vulnerable to sleep problems during times of reproductive hormonal change, such as after the menopausal transition. Menopause is âÂÂthe kamagra uk delivery permanent cessation of menstruation that occurs after the loss of ovarian activityâ (3). This data brief describes sleep duration and sleep quality among nonpregnant women aged 40âÂÂ59 by menopausal status. The age range selected for this analysis reflects the focus on midlife sleep health. In this analysis, 74.2% of women are premenopausal, 3.7% are perimenopausal, and 22.1% are postmenopausal kamagra uk delivery. Keywords. Insufficient sleep, menopause, National Health Interview Survey Perimenopausal women were more likely than premenopausal and postmenopausal women to sleep less than 7 hours, on average, in a 24-hour period.More than one in three nonpregnant women aged 40âÂÂ59 kamagra uk delivery slept less than 7 hours, on average, in a 24-hour period (35.1%) (Figure 1). Perimenopausal women were most likely to sleep less than 7 hours, on average, in a 24-hour period (56.0%), compared with 32.5% of premenopausal and 40.5% of postmenopausal women. Postmenopausal women were significantly more likely than premenopausal women to sleep less than 7 hours, on average, in a 24-hour period. Figure 1 kamagra uk delivery. Percentage of nonpregnant women aged 40âÂÂ59 who slept less than 7 hours, on average, in a 24-hour period, by menopausal status. United States, kamagra uk delivery 2015image icon1Significant quadratic trend by menopausal status (p <. 0.05).NOTES. Women were postmenopausal if they had gone without a menstrual cycle for more than 1 year or were in surgical menopause after the removal of their ovaries. Women were perimenopausal if they no longer had a menstrual cycle and their kamagra uk delivery last menstrual cycle was 1 year ago or less. Women were premenopausal if they still had a menstrual cycle. Access data kamagra uk delivery table for Figure 1pdf icon.SOURCE. NCHS, National Health Interview Survey, 2015. The percentage of women aged 40âÂÂ59 who had trouble falling kamagra uk delivery asleep four times or more in the past week varied by menopausal status.Nearly one in five nonpregnant women aged 40âÂÂ59 had trouble falling asleep four times or more in the past week (19.4%) (Figure 2). The percentage of women in this age group who had trouble falling asleep four times or more in the past week increased from 16.8% among premenopausal women to 24.7% among perimenopausal and 27.1% among postmenopausal women. Postmenopausal women were significantly more likely than premenopausal women to have trouble falling asleep four times or more in the past week. Figure 2 kamagra uk delivery. Percentage of nonpregnant women aged 40âÂÂ59 who had trouble falling asleep four times or more in the past week, by menopausal status. United States, kamagra uk delivery 2015image icon1Significant linear trend by menopausal status (p <. 0.05).NOTES. Women were postmenopausal if they had gone without a menstrual cycle for more than 1 year or were in surgical menopause after the removal of their ovaries. Women were perimenopausal if they no longer had a menstrual cycle and their last menstrual cycle was 1 year kamagra uk delivery ago or less. Women were premenopausal if they still had a menstrual cycle. Access data table for Figure 2pdf kamagra uk delivery icon.SOURCE. NCHS, National Health Interview Survey, 2015. The percentage of women aged 40âÂÂ59 who had trouble staying asleep four times or more in the past week varied by menopausal status.More than one in four nonpregnant women aged 40âÂÂ59 had kamagra uk delivery trouble staying asleep four times or more in the past week (26.7%) (Figure 3). The percentage of women aged 40âÂÂ59 who had trouble staying asleep four times or more in the past week increased from 23.7% among premenopausal, to 30.8% among perimenopausal, and to 35.9% among postmenopausal women. Postmenopausal women were significantly more likely than premenopausal women to have trouble staying asleep four times or more in the past week. Figure 3 kamagra uk delivery. Percentage of nonpregnant women aged 40âÂÂ59 who had trouble staying asleep four times or more in the past week, by menopausal status. United States, 2015image icon1Significant linear trend by kamagra uk delivery menopausal status (p <. 0.05).NOTES. Women were postmenopausal if they had gone without a menstrual cycle for more than 1 year or were in surgical menopause after the removal of their ovaries. Women were perimenopausal if they no longer had a menstrual cycle and their last menstrual cycle was 1 year kamagra uk delivery ago or less. Women were premenopausal if they still had a menstrual cycle. Access data kamagra uk delivery table for Figure 3pdf icon.SOURCE. NCHS, National Health Interview Survey, 2015. The percentage of women aged 40âÂÂ59 who did not wake up feeling well rested 4 days or more in the past week varied by menopausal status.Nearly one in two nonpregnant women aged 40âÂÂ59 did not wake up feeling well rested 4 days or more in the past week (48.9%) (Figure 4). The percentage of women in this age group who did not wake up feeling well rested 4 days or more in the past kamagra uk delivery week increased from 47.0% among premenopausal women to 49.9% among perimenopausal and 55.1% among postmenopausal women. Postmenopausal women were significantly more likely than premenopausal women to not wake up feeling well rested 4 days or more in the past week. Figure 4 kamagra uk delivery. Percentage of nonpregnant women aged 40âÂÂ59 who did not wake up feeling well rested 4 days or more in the past week, by menopausal status. United States, 2015image icon1Significant linear trend by menopausal status (p <. 0.05).NOTES. Women were postmenopausal if they had gone without a menstrual cycle for more than 1 year or were in surgical menopause after the removal of their ovaries. Women were perimenopausal if they no longer had a menstrual cycle and their last menstrual cycle was 1 year ago or less. Women were premenopausal if they still had a menstrual cycle. Access data table for Figure 4pdf icon.SOURCE. NCHS, National Health Interview Survey, 2015. SummaryThis report describes sleep duration and sleep quality among U.S. Nonpregnant women aged 40âÂÂ59 by menopausal status. Perimenopausal women were most likely to sleep less than 7 hours, on average, in a 24-hour period compared with premenopausal and postmenopausal women. In contrast, postmenopausal women were most likely to have poor-quality sleep. A greater percentage of postmenopausal women had frequent trouble falling asleep, staying asleep, and not waking well rested compared with premenopausal women. The percentage of perimenopausal women with poor-quality sleep was between the percentages for the other two groups in all three categories. Sleep duration changes with advancing age (4), but sleep duration and quality are also influenced by concurrent changes in womenâÂÂs reproductive hormone levels (5). Because sleep is critical for optimal health and well-being (6), the findings in this report highlight areas for further research and targeted health promotion. DefinitionsMenopausal status. A three-level categorical variable was created from a series of questions that asked women. 1) âÂÂHow old were you when your periods or menstrual cycles started?. ÃÂÂ. 2) âÂÂDo you still have periods or menstrual cycles?. ÃÂÂ. 3) âÂÂWhen did you have your last period or menstrual cycle?. ÃÂÂ. And 4) âÂÂHave you ever had both ovaries removed, either as part of a hysterectomy or as one or more separate surgeries?. àWomen were postmenopausal if they a) had gone without a menstrual cycle for more than 1 year or b) were in surgical menopause after the removal of their ovaries. Women were perimenopausal if they a) no longer had a menstrual cycle and b) their last menstrual cycle was 1 year ago or less. Premenopausal women still had a menstrual cycle.Not waking feeling well rested. Determined by respondents who answered 3 days or less on the questionnaire item asking, âÂÂIn the past week, on how many days did you wake up feeling well rested?. ÃÂÂShort sleep duration. Determined by respondents who answered 6 hours or less on the questionnaire item asking, âÂÂOn average, how many hours of sleep do you get in a 24-hour period?. ÃÂÂTrouble falling asleep. Determined by respondents who answered four times or more on the questionnaire item asking, âÂÂIn the past week, how many times did you have trouble falling asleep?. ÃÂÂTrouble staying asleep. Determined by respondents who answered four times or more on the questionnaire item asking, âÂÂIn the past week, how many times did you have trouble staying asleep?. àData source and methodsData from the 2015 National Health Interview Survey (NHIS) were used for this analysis. NHIS is a multipurpose health survey conducted continuously throughout the year by the National Center for Health Statistics. Interviews are conducted in person in respondentsâ homes, but follow-ups to complete interviews may be conducted over the telephone. Data for this analysis came from the Sample Adult core and cancer supplement sections of the 2015 NHIS. For more information about NHIS, including the questionnaire, visit the NHIS website.All analyses used weights to produce national estimates. Estimates on sleep duration and quality in this report are nationally representative of the civilian, noninstitutionalized nonpregnant female population aged 40âÂÂ59 living in households across the United States. The sample design is described in more detail elsewhere (7). Point estimates and their estimated variances were calculated using SUDAAN software (8) to account for the complex sample design of NHIS. Linear and quadratic trend tests of the estimated proportions across menopausal status were tested in SUDAAN via PROC DESCRIPT using the POLY option. Differences between percentages were evaluated using two-sided significance tests at the 0.05 level. About the authorAnjel Vahratian is with the National Center for Health Statistics, Division of Health Interview Statistics. The author gratefully acknowledges the assistance of Lindsey Black in the preparation of this report. ReferencesFord ES. Habitual sleep duration and predicted 10-year cardiovascular risk using the pooled cohort risk equations among US adults. J Am Heart Assoc 3(6):e001454. 2014.Ford ES, Wheaton AG, Chapman DP, Li C, Perry GS, Croft JB. Associations between self-reported sleep duration and sleeping disorder with concentrations of fasting and 2-h glucose, insulin, and glycosylated hemoglobin among adults without diagnosed diabetes. J Diabetes 6(4):338âÂÂ50. 2014.American College of Obstetrics and Gynecology. ACOG Practice Bulletin No. 141. Management of menopausal symptoms. Obstet Gynecol 123(1):202âÂÂ16. 2014.Black LI, Nugent CN, Adams PF. Tables of adult health behaviors, sleep. National Health Interview Survey, 2011âÂÂ2014pdf icon. 2016.Santoro N. Perimenopause. From research to practice. J WomenâÂÂs Health (Larchmt) 25(4):332âÂÂ9. 2016.Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, et al. Recommended amount of sleep for a healthy adult. A joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. J Clin Sleep Med 11(6):591âÂÂ2. 2015.Parsons VL, Moriarity C, Jonas K, et al. Design and estimation for the National Health Interview Survey, 2006âÂÂ2015. National Center for Health Statistics. Vital Health Stat 2(165). 2014.RTI International. SUDAAN (Release 11.0.0) [computer software]. 2012. Suggested citationVahratian A. Sleep duration and quality among women aged 40âÂÂ59, by menopausal status. NCHS data brief, no 286. Hyattsville, MD. National Center for Health Statistics. 2017.Copyright informationAll material appearing in this report is in the public domain and may be reproduced or copied without permission. Citation as to source, however, is appreciated.National Center for Health StatisticsCharles J. Rothwell, M.S., M.B.A., DirectorJennifer H. Madans, Ph.D., Associate Director for ScienceDivision of Health Interview StatisticsMarcie L. Cynamon, DirectorStephen J. Blumberg, Ph.D., Associate Director for Science. NCHS Data kamagra online without prescription http://ptandpilates.com/propecia-5mg-cost Brief No. 286, September 2017PDF Versionpdf icon (374 KB)Anjel Vahratian, Ph.D.Key findingsData from the National Health Interview Survey, 2015Among those aged 40âÂÂ59, perimenopausal women (56.0%) were more likely than postmenopausal (40.5%) and premenopausal (32.5%) women to sleep less than 7 hours, on average, in a 24-hour period.Postmenopausal women aged 40âÂÂ59 were more likely than premenopausal women aged 40âÂÂ59 to have trouble falling asleep (27.1% compared with 16.8%, respectively), and staying asleep (35.9% compared with 23.7%), four times or more in the past week.Postmenopausal women aged 40âÂÂ59 (55.1%) were more likely than premenopausal women aged 40âÂÂ59 (47.0%) to not wake up feeling well rested 4 days or more in the past week.Sleep duration and quality are important contributors to health and wellness. Insufficient sleep is kamagra online without prescription associated with an increased risk for chronic conditions such as cardiovascular disease (1) and diabetes (2). Women may be particularly vulnerable to sleep problems during times of reproductive hormonal change, such as after the menopausal transition. Menopause is âÂÂthe permanent cessation of menstruation kamagra online without prescription that occurs after the loss of ovarian activityâ (3). This data brief describes sleep duration and sleep quality among nonpregnant women aged 40âÂÂ59 by menopausal status. The age range selected for this analysis reflects the focus on midlife sleep health. In this analysis, 74.2% kamagra online without prescription of women are premenopausal, 3.7% are perimenopausal, and 22.1% are postmenopausal. Keywords. Insufficient sleep, menopause, National Health Interview Survey Perimenopausal women were more likely than premenopausal and postmenopausal women to sleep less than 7 hours, on average, in a 24-hour period.More than one in three nonpregnant kamagra online without prescription women aged 40âÂÂ59 slept less than 7 hours, on average, in a 24-hour period (35.1%) (Figure 1). Perimenopausal women were most likely to sleep less than 7 hours, on average, in a 24-hour period (56.0%), compared with 32.5% of premenopausal and 40.5% of postmenopausal women. Postmenopausal women were significantly more likely than premenopausal women to sleep less than 7 hours, on average, in a 24-hour period. Figure 1 kamagra online without prescription. Percentage of nonpregnant women aged 40âÂÂ59 who slept less than 7 hours, on average, in a 24-hour period, by menopausal status. United States, 2015image icon1Significant quadratic trend kamagra online without prescription by menopausal status (p <. 0.05).NOTES. Women were postmenopausal if they had gone without a menstrual cycle for more than 1 year or were in surgical menopause after the removal of their ovaries. Women were perimenopausal if they no longer had a menstrual cycle and their last kamagra online without prescription menstrual cycle was 1 year ago or less. Women were premenopausal if they still had a menstrual cycle. Access data table for Figure 1pdf icon.SOURCE kamagra online without prescription. NCHS, National Health Interview Survey, 2015. The percentage of women aged 40âÂÂ59 who had trouble falling asleep four times or more in the past week varied by menopausal status.Nearly one in five nonpregnant women aged 40âÂÂ59 had trouble falling asleep four times or more in the past kamagra online without prescription week (19.4%) (Figure 2). The percentage of women in this age group who had trouble falling asleep four times or more in the past week increased from 16.8% among premenopausal women to 24.7% among perimenopausal and 27.1% among postmenopausal women. Postmenopausal women were significantly more likely than premenopausal women to have trouble falling asleep four times or more in the past week. Figure 2 kamagra online without prescription. Percentage of nonpregnant women aged 40âÂÂ59 who had trouble falling asleep four times or more in the past week, by menopausal status. United States, 2015image icon1Significant linear kamagra online without prescription trend by menopausal status (p <. 0.05).NOTES. Women were postmenopausal if they had gone without a menstrual cycle for more than 1 year or were in surgical menopause after the removal of their ovaries. Women were perimenopausal if they no kamagra online without prescription longer had a menstrual cycle and their last menstrual cycle was 1 year ago or less. Women were premenopausal if they still had a menstrual cycle. Access data table for Figure 2pdf kamagra online without prescription icon.SOURCE. NCHS, National Health Interview Survey, 2015. The percentage of women aged 40âÂÂ59 who had trouble staying asleep four times or more in the past week varied by menopausal status.More than one in four nonpregnant women aged 40âÂÂ59 had trouble staying asleep four times or more in kamagra online without prescription the past week (26.7%) (Figure 3). The percentage of women aged 40âÂÂ59 who had trouble staying asleep four times or more in the past week increased from 23.7% among premenopausal, to 30.8% among perimenopausal, and to 35.9% among postmenopausal women. Postmenopausal women were significantly more likely than premenopausal women to have trouble staying asleep four times or more in the past week. Figure 3 kamagra online without prescription. Percentage of nonpregnant women aged 40âÂÂ59 who had trouble staying asleep four times or more in the past week, by menopausal status. United States, 2015image icon1Significant linear kamagra online without prescription trend by menopausal status (p <. 0.05).NOTES. Women were postmenopausal if they had gone without a menstrual cycle for more than 1 year or were in surgical menopause after the removal of their ovaries. Women were perimenopausal if they no longer kamagra online without prescription had a menstrual cycle and their last menstrual cycle was 1 year ago or less. Women were premenopausal if they still had a menstrual cycle. Access data kamagra online without prescription table for Figure 3pdf icon.SOURCE. NCHS, National Health Interview Survey, 2015. The percentage of women aged 40âÂÂ59 who did not wake up feeling well rested 4 days or more in the past week varied by menopausal status.Nearly one in two nonpregnant women aged 40âÂÂ59 did not wake up feeling well rested 4 days or more in the past week (48.9%) (Figure 4). The percentage of women in this age group who did not kamagra online without prescription wake up feeling well rested 4 days or more in the past week increased from 47.0% among premenopausal women to 49.9% among perimenopausal and 55.1% among postmenopausal women. Postmenopausal women were significantly more likely than premenopausal women to not wake up feeling well rested 4 days or more in the past week. Figure 4 kamagra online without prescription. Percentage of nonpregnant women aged 40âÂÂ59 who did not wake up feeling well rested 4 days or more in the past week, by menopausal status. United States, 2015image icon1Significant linear trend by menopausal status (p <. 0.05).NOTES. Women were postmenopausal if they had gone without a menstrual cycle for more than 1 year or were in surgical menopause after the removal of their ovaries. Women were perimenopausal if they no longer had a menstrual cycle and their last menstrual cycle was 1 year ago or less. Women were premenopausal if they still had a menstrual cycle. Access data table for Figure 4pdf icon.SOURCE. NCHS, National Health Interview Survey, 2015. SummaryThis report describes sleep duration and sleep quality among U.S. Nonpregnant women aged 40âÂÂ59 by menopausal status. Perimenopausal women were most likely to sleep less than 7 hours, on average, in a 24-hour period compared with premenopausal and postmenopausal women. In contrast, postmenopausal women were most likely to have poor-quality sleep. A greater percentage of postmenopausal women had frequent trouble falling asleep, staying asleep, and not waking well rested compared with premenopausal women. The percentage of perimenopausal women with poor-quality sleep was between the percentages for the other two groups in all three categories. Sleep duration changes with advancing age (4), but sleep duration and quality are also influenced by concurrent changes in womenâÂÂs reproductive hormone levels (5). Because sleep is critical for optimal health and well-being (6), the findings in this report highlight areas for further research and targeted health promotion. DefinitionsMenopausal status. A three-level categorical variable was created from a series of questions that asked women. 1) âÂÂHow old were you when your periods or menstrual cycles started?. ÃÂÂ. 2) âÂÂDo you still have periods or menstrual cycles?. ÃÂÂ. 3) âÂÂWhen did you have your last period or menstrual cycle?. ÃÂÂ. And 4) âÂÂHave you ever had both ovaries removed, either as part of a hysterectomy or as one or more separate surgeries?. àWomen were postmenopausal if they a) had gone without a menstrual cycle for more than 1 year or b) were in surgical menopause after the removal of their ovaries. Women were perimenopausal if they a) no longer had a menstrual cycle and b) their last menstrual cycle was 1 year ago or less. Premenopausal women still had a menstrual cycle.Not waking feeling well rested. Determined by respondents who answered 3 days or less on the questionnaire item asking, âÂÂIn the past week, on how many days did you wake up feeling well rested?. ÃÂÂShort sleep duration. Determined by respondents who answered 6 hours or less on the questionnaire item asking, âÂÂOn average, how many hours of sleep do you get in a 24-hour period?. ÃÂÂTrouble falling asleep. Determined by respondents who answered four times or more on the questionnaire item asking, âÂÂIn the past week, how many times did you have trouble falling asleep?. ÃÂÂTrouble staying asleep. Determined by respondents who answered four times or more on the questionnaire item asking, âÂÂIn the past week, how many times did you have trouble staying asleep?. àData source and methodsData from the 2015 National Health Interview Survey (NHIS) were used for this analysis. NHIS is a multipurpose health survey conducted continuously throughout the year by the National Center for Health Statistics. Interviews are conducted in person in respondentsâ homes, but follow-ups to complete interviews may be conducted over the telephone. Data for this analysis came from the Sample Adult core and cancer supplement sections of the 2015 NHIS. For more information about NHIS, including the questionnaire, visit the NHIS website.All analyses used weights to produce national estimates. Estimates on sleep duration and quality in this report are nationally representative of the civilian, noninstitutionalized nonpregnant female population aged 40âÂÂ59 living in households across the United States. The sample design is described in more detail elsewhere (7). Point estimates and their estimated variances were calculated using SUDAAN software (8) to account for the complex sample design of NHIS. Linear and quadratic trend tests of the estimated proportions across menopausal status were tested in SUDAAN via PROC DESCRIPT using the POLY option. Differences between percentages were evaluated using two-sided significance tests at the 0.05 level. About the authorAnjel Vahratian is with the National Center for Health Statistics, Division of Health Interview Statistics. The author gratefully acknowledges the assistance of Lindsey Black in the preparation of this report. ReferencesFord ES. Habitual sleep duration and predicted 10-year cardiovascular risk using the pooled cohort risk equations among US adults. J Am Heart Assoc 3(6):e001454. 2014.Ford ES, Wheaton AG, Chapman DP, Li C, Perry GS, Croft JB. Associations between self-reported sleep duration and sleeping disorder with concentrations of fasting and 2-h glucose, insulin, and glycosylated hemoglobin among adults without diagnosed diabetes. J Diabetes 6(4):338âÂÂ50. 2014.American College of Obstetrics and Gynecology. ACOG Practice Bulletin No. 141. Management of menopausal symptoms. Obstet Gynecol 123(1):202âÂÂ16. 2014.Black LI, Nugent CN, Adams PF. Tables of adult health behaviors, sleep. National Health Interview Survey, 2011âÂÂ2014pdf icon. 2016.Santoro N. Perimenopause. From research to practice. J WomenâÂÂs Health (Larchmt) 25(4):332âÂÂ9. 2016.Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, et al. Recommended amount of sleep for a healthy adult. A joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. J Clin Sleep Med 11(6):591âÂÂ2. 2015.Parsons VL, Moriarity C, Jonas K, et al. Design and estimation for the National Health Interview Survey, 2006âÂÂ2015. National Center for Health Statistics. Vital Health Stat 2(165). 2014.RTI International. SUDAAN (Release 11.0.0) [computer software]. 2012. Suggested citationVahratian A. Sleep duration and quality among women aged 40âÂÂ59, by menopausal status. NCHS data brief, no 286. Hyattsville, MD. National Center for Health Statistics. 2017.Copyright informationAll material appearing in this report is in the public domain and may be reproduced or copied without permission. Citation as to source, however, is appreciated.National Center for Health StatisticsCharles J. Rothwell, M.S., M.B.A., DirectorJennifer H. Madans, Ph.D., Associate Director for ScienceDivision of Health Interview StatisticsMarcie L. Cynamon, DirectorStephen J. Blumberg, Ph.D., Associate Director for Science. Ajanta pharma kamagra jellyAs it looks to emerge from bankruptcy, Mallinckrodt (MNK) has sold an experimental medicine ajanta pharma kamagra jelly that until recently was being tested to treat a fatal genetic disorder. But the company has said it will work with the buyer to ensure it remains available to children, an unexpected twist in the latest controversy over access the drug.At issue is a medication called adrabetadex, which the ajanta pharma kamagra jelly company was studying to combat Niemann-Pick type C, or NPC, a rare progressive genetic disorder characterized by an inability of the body to transport cholesterol and other fatty substances inside of cells. The life expectancy of someone with the condition is about 20 years, but can be much shorter if NPC emerges during infancy.Mallinckrodt, which obtained the drug as part of its $1.2 billion acquisition of Sucampo Pharmaceuticals in late 2017, ended clinical testing earlier this year after studies indicated the drug had no benefit. It was a devastating decision for families, because there is currently no treatment for NPC that has been approved for use in the U.S.advertisement âÂÂAfter five treatments, my daughter started walking,â said Sara McGlocklin of ajanta pharma kamagra jelly Monrovia, Calif., whose five-year-old daughter, Marian, was diagnosed with NPC when she was a toddler and later had difficulty talking and walking. ÃÂÂBefore treatment, it would take her six months to hit a new milestone. But after each ajanta pharma kamagra jelly treatment, she hit a new milestone. It was like a light switch turned on.âÂÂAfter at least two possible buyers did not pan out, Mallinckrodt reached a deal on Wednesday to sell the drug to ajanta pharma kamagra jelly a little-known company called Mandos for $1 million and $2 million more in milestone payments, according to court documents. And Mallinckrodt agreed to secure enough supply to allow access to the drug for potentially up to two years under expanded access.advertisement Expanded access, sometimes known as compassionate use, is a program overseen by the Food and Drug Administration in which a drug maker can agree to provide its medicine to patients with a life-threatening disease receive an experimental medicine, even though they are not enrolled in a clinical trial. For the past several months, however, some families have attempted to gain access to the program ajanta pharma kamagra jelly for their children. But theyâÂÂve been turned away for reasons that in some cases have been unclear. The FDA and Mallinckrodt appeared to point fingers at one another over who is to blame for the obstacles, according to families and a Rush University Medical Center researcher in Chicago who has helped pilot the expanded access program.âÂÂItâÂÂs been very hard to get to the truth,â said ajanta pharma kamagra jelly Elizabeth Berry-Kravis, a pediatrics and neurology professor at Rush, who has been in close contact with numerous families, as well as both agency and company officials. ÃÂÂThe statements have been contradictory.âÂÂâÂÂMallinckrodt released a statement implying the FDA had required them to stop enrolling new patients as part of ending their development program,â she told me. ÃÂÂYou have to read between ajanta pharma kamagra jelly the lines, though. But theyâÂÂve ajanta pharma kamagra jelly told me that was the situation. FDA has not officially said thatâÂÂs the case. But in e-mails to me, (an FDA official) has said âÂÂNo, I canâÂÂt allow it, itâÂÂs not an FDA program.'âÂÂA spokesperson for Mallinckrodt maintained that it was a âÂÂmischaracterizationâ for anyone ajanta pharma kamagra jelly to suggest that the company was blaming the FDA. However, in an e-mail Mallinckrodt sent previously to researchers, the company acknowledged that, as part of its agreement with FDA to continue the expanded access program through October, it agreed âÂÂno new patientsâ would be able to start the drug. Last week, however, Katie Donohue, the director of the Division of Rare Diseases and Medical Genetics â who Berry-Kravis said was the FDA official who would not allow additional children in the expanded access ajanta pharma kamagra jelly program â changed her mind. In a note to one parent, she wrote that Mallinckrodt has ajanta pharma kamagra jelly final say. ÃÂÂWe canâÂÂt force them to do that,â Donohue.That note was sent to Denise Miller of Sun City West, Ariz., whose 22-month-old son, Woodrow, was recently prevented from enrolling in the expanded access program. Miller forwarded the note to Steve Romano, executive vice president and chief scientific officer at Mallinckrodt, who wrote back ajanta pharma kamagra jelly to say the company was âÂÂevaluating the situation and potential options, and hope(s) to reach a conclusion within the next few days.âÂÂDenise Miller and Rickey Miller with their son Woodrow Miller, who has Niemann-Pick type C. Courtesy Denise MillerThe sudden change of heart appears to reflect a few developments, including growing pressure on the FDA. Berry-Kravis and several other physicians who treat children with NPC, last month wrote a letter to Acting FDA ajanta pharma kamagra jelly Commissioner Janet Woodcock, urging her to accept new patients in the expanded access program. They cited studies indicating adrabetadex stabilized the disease over an extended period of time. In addition, several lawmakers recently began reaching ajanta pharma kamagra jelly out to the Department of Health and Human Services, as well as the FDA, to make the same push.âÂÂGiven the extreme urgency for (children) to receive this medicine, I am writing to ask you to use the many authorities and resources in your control to provide access⦠to this critical therapy and to act immediately,â Rep. Debbie Lesko (R-Ariz.), wrote to ajanta pharma kamagra jelly Woodcock on May 5. She also cited the same letter that was written by the physicians.To an extent, the episode is reminiscent of earlier criticism of the FDA and its expanded access program, even though the agency has produced data showing more than 99% of requests are approved. The agency, in fact, is particularly sensitive about the issue after critics succeeded in getting the right-to-try law passed, even though drug makers remain gatekeepers for deciding who can access it medicines.Patrizia Cavazzoni, the director of the Center for Drug Evaluation and Research, told us she could not comment on communications ajanta pharma kamagra jelly between specific individuals. But she did explain that the agency was keenly aware of the controversy surrounding adrabetadex and has remained âÂÂgenerally supportiveâ of some form of expanded access.âÂÂFrom the centerâÂÂs perspective, weâÂÂve been working to find a path forward⦠under some form of expanded access. WeâÂÂre still deliberating on this because we do recognize ajanta pharma kamagra jelly there may be some patients who may benefit,â she said. ÃÂÂThis has been my position from the very onset of the discussion weâÂÂve had⦠And weâÂÂre certainly open to it if the sponsor were to come and talk ajanta pharma kamagra jelly to us about doing more studies.âÂÂMeanwhile, there was another development that appeared to break the logjam.For the past year, Mallinckrodt had been exploring whether it could find a buyer for the drug. The company had filed for bankruptcy protection in response to mounting liabilities over lawsuits that accused it of contributing to the opioid crisis. Romano told parents earlier this year that the bankruptcy was not the reason trials were ended for adrabetadex, though.Under the deal with ajanta pharma kamagra jelly Mandos, Mallinckrodt has agreed to secure enough doses to enable expanded access for up two years.âÂÂMallinckrodt as worked judiciously to identify an entity that would seek to find a path forward for the drug,â Romano said in a statement. ÃÂÂWe are hopeful Mandos will further advance both the understanding of the disease and the potential to develop the drug as a future treatment option for NPC patients.â Whether Mandos can achieve this goal is unclear.The company issued a statement noting, that if the deal is approved by the bankruptcy court, it will continue the expanded access program and it will be overseen by Berry-Kravis. But there were ajanta pharma kamagra jelly no further details provided. Scott Riccio, the executive vice president for patient and community engagement, did not respond to an e-mail.RiccioâÂÂs LinkedIn notes he previously held similar positions at Myovant Sciences and Alder Pharmaceuticals and indicates he began working this month at a âÂÂstealth biotech startup.â Court documents, meanwhile, list Mandos as being headquartered on Sunset Boulevard in West Hollywood, Ca. A generic voice mail answers the phone number listed in court documents.Interestingly, one of the Mallinckrodt creditors, Beren Therapeutics, is located at the same address â the same suite number, in fact â according to a filing with ajanta pharma kamagra jelly the California Secretary of State. And the Beren chief executive officer is listed as ajanta pharma kamagra jelly Jason Camm, whose LinkedIn page says he is managing director and chief medical officer at Thiel Capital, which is in the same building as both entities.Thiel Capital is the investment run by Peter Thiel, a venture capitalist who co-founded PayPal and Palantir Technologies, among other companies. We left word for Camm and will update you any reply.The lack of insight into Mandos and its ability to develop adrabetadex and run an expanded access program has some parents concerned, although bankruptcy documents indicate Mallinckrodt will help run the program for three months after the deal closes, for a fee.âÂÂItâÂÂs validating to know investors out there see the value in this drug, because I think the thing whatâÂÂs been so frustrating for me as a mom. Our reality has never aligned with the narrative about the drug,â said Pam Andrews of Austin, Tex., who has two daughters suffering from NPC.âÂÂBut I donâÂÂt know if the company has the experience to work with the FDA ajanta pharma kamagra jelly to get them what they say they need. IâÂÂm scared for the kids. ThereâÂÂs zero room for error ajanta pharma kamagra jelly and thereâÂÂs still so much uncertainty. It seems like a big mess.âÂÂ. As it looks to emerge from bankruptcy, Mallinckrodt (MNK) has sold an http://mpa.ms/viagra-price-cvs/ experimental medicine that until recently was being kamagra online without prescription tested to treat a fatal genetic disorder. But the company has said it will work with the buyer to ensure it remains available to children, an unexpected twist in the latest controversy over access the drug.At issue kamagra online without prescription is a medication called adrabetadex, which the company was studying to combat Niemann-Pick type C, or NPC, a rare progressive genetic disorder characterized by an inability of the body to transport cholesterol and other fatty substances inside of cells. The life expectancy of someone with the condition is about 20 years, but can be much shorter if NPC emerges during infancy.Mallinckrodt, which obtained the drug as part of its $1.2 billion acquisition of Sucampo Pharmaceuticals in late 2017, ended clinical testing earlier this year after studies indicated the drug had no benefit. It was a devastating decision for families, because there is currently no treatment for NPC that has been approved for use in the U.S.advertisement âÂÂAfter five treatments, my daughter started walking,â said Sara McGlocklin of Monrovia, Calif., whose five-year-old daughter, Marian, was diagnosed with NPC when she was a toddler and later kamagra online without prescription had difficulty talking and walking. ÃÂÂBefore treatment, it would take her six months to hit a new milestone. But after each treatment, she kamagra online without prescription hit a new milestone. It was like a light switch turned on.âÂÂAfter at least two kamagra online without prescription possible buyers did not pan out, Mallinckrodt reached a deal on Wednesday to sell the drug to a little-known company called Mandos for $1 million and $2 million more in milestone payments, according to court documents. And Mallinckrodt agreed to secure enough supply to allow access to the drug for potentially up to two years under expanded access.advertisement Expanded access, sometimes known as compassionate use, is a program overseen by the Food and Drug Administration in which a drug maker can agree to provide its medicine to patients with a life-threatening disease receive an experimental medicine, even though they are not enrolled in a clinical trial. For the past several months, however, some families have attempted to gain access to the kamagra online without prescription program for their children. But theyâÂÂve been turned away for reasons that in some cases have been unclear. The FDA and Mallinckrodt appeared to point fingers at one another over who is to blame for kamagra online without prescription the obstacles, according to families and a Rush University Medical Center researcher in Chicago who has helped pilot the expanded access program.âÂÂItâÂÂs been very hard to get to the truth,â said Elizabeth Berry-Kravis, a pediatrics and neurology professor at Rush, who has been in close contact with numerous families, as well as both agency and company officials. ÃÂÂThe statements have been contradictory.âÂÂâÂÂMallinckrodt released a statement implying the FDA had required them to stop enrolling new patients as part of ending their development program,â she told me. ÃÂÂYou have to kamagra online without prescription read between the lines, though. But theyâÂÂve told me that was the situation kamagra online without prescription. FDA has not officially said thatâÂÂs the case. But in e-mails kamagra online without prescription to me, (an FDA official) has said âÂÂNo, I canâÂÂt allow it, itâÂÂs not an FDA program.'âÂÂA spokesperson for Mallinckrodt maintained that it was a âÂÂmischaracterizationâ for anyone to suggest that the company was blaming the FDA. However, in an e-mail Mallinckrodt sent previously to researchers, the company acknowledged that, as part of its agreement with FDA to continue the expanded access program through October, it agreed âÂÂno new patientsâ would be able to start the drug. Last week, however, Katie Donohue, the director of the Division of Rare Diseases and Medical Genetics â who Berry-Kravis said was the FDA official who would not allow additional children in the expanded access kamagra online without prescription program â changed her mind. In a kamagra online without prescription note to one parent, she wrote that Mallinckrodt has final say. ÃÂÂWe canâÂÂt force them to do that,â Donohue.That note was sent to Denise Miller of Sun City West, Ariz., whose 22-month-old son, Woodrow, was recently prevented from enrolling in the expanded access program. Miller forwarded the note to Steve Romano, executive vice president and chief scientific officer at Mallinckrodt, who wrote back to say the company was âÂÂevaluating the situation and potential options, and hope(s) to reach kamagra online without prescription a conclusion within the next few days.âÂÂDenise Miller and Rickey Miller with their son Woodrow Miller, who has Niemann-Pick type C. Courtesy Denise MillerThe sudden change of heart appears to reflect a few developments, including growing pressure on the FDA. Berry-Kravis and several other physicians who treat children with NPC, last month wrote a letter to kamagra online without prescription Acting FDA Commissioner Janet Woodcock, urging her to accept new patients in the expanded access program. They cited studies indicating adrabetadex stabilized the disease over an extended period of time. In addition, several lawmakers recently began reaching out to the Department of Health and Human Services, as well as the FDA, to make the same push.âÂÂGiven the extreme urgency for (children) to receive this medicine, I am writing kamagra online without prescription to ask you to use the many authorities and resources in your control to provide access⦠to this critical therapy and to act immediately,â Rep. Debbie Lesko (R-Ariz.), wrote to Woodcock kamagra online without prescription on May 5. She also cited the same letter that was written by the physicians.To an extent, the episode is reminiscent of earlier criticism of the FDA and its expanded access program, even though the agency has produced data showing more than 99% of requests are approved. The agency, in fact, is particularly sensitive about the issue after critics succeeded in getting the right-to-try law passed, even though drug makers remain gatekeepers for deciding who can access it medicines.Patrizia Cavazzoni, the director of the Center for Drug Evaluation and Research, told us she could not comment on kamagra online without prescription communications between specific individuals. But she did explain that the agency was keenly aware of the controversy surrounding adrabetadex and has remained âÂÂgenerally supportiveâ of some form of expanded access.âÂÂFrom the centerâÂÂs perspective, weâÂÂve been working to find a path forward⦠under some form of expanded access. WeâÂÂre still deliberating on this because we do recognize there may be some patients who may benefit,â she kamagra online without prescription said. ÃÂÂThis has been my position from the very onset of the discussion weâÂÂve had⦠And weâÂÂre certainly open to it if the sponsor were to come and talk to us about doing kamagra online without prescription more studies.âÂÂMeanwhile, there was another development that appeared to break the logjam.For the past year, Mallinckrodt had been exploring whether it could find a buyer for the drug. The company had filed for bankruptcy protection in response to mounting liabilities over lawsuits that accused it of contributing to the opioid crisis. Romano told parents earlier this year that the bankruptcy was not the reason trials were ended for adrabetadex, though.Under the deal with Mandos, Mallinckrodt has agreed kamagra online without prescription to secure enough doses to enable expanded access for up two years.âÂÂMallinckrodt as worked judiciously to identify an entity that would seek to find a path forward for the drug,â Romano said in a statement. ÃÂÂWe are hopeful Mandos will further advance both the understanding of the disease and the potential to develop the drug as a future treatment option for NPC patients.â Whether Mandos can achieve this goal is unclear.The company issued a statement noting, that if the deal is approved by the bankruptcy court, it will continue the expanded access program and it will be overseen by Berry-Kravis. But there were no kamagra online without prescription further details provided. Scott Riccio, the executive vice president for patient and community engagement, did not respond to an e-mail.RiccioâÂÂs LinkedIn notes he previously held similar positions at Myovant Sciences and Alder Pharmaceuticals and indicates he began working this month at a âÂÂstealth biotech startup.â Court documents, meanwhile, list Mandos as being headquartered on Sunset Boulevard in West Hollywood, Ca. A generic voice mail answers the phone number listed in court documents.Interestingly, one of the Mallinckrodt creditors, Beren Therapeutics, is kamagra online without prescription located at the same address â the same suite number, in fact â according to a filing with the California Secretary of State. And the Beren chief executive officer is listed as Jason Camm, whose LinkedIn page says kamagra online without prescription he is managing director and chief medical officer at Thiel Capital, which is in the same building as both entities.Thiel Capital is the investment run by Peter Thiel, a venture capitalist who co-founded PayPal and Palantir Technologies, among other companies. We left word for Camm and will update you any reply.The lack of insight into Mandos and its ability to develop adrabetadex and run an expanded access program has some parents concerned, although bankruptcy documents indicate Mallinckrodt will help run the program for three months after the deal closes, for a fee.âÂÂItâÂÂs validating to know investors out there see the value in this drug, because I think the thing whatâÂÂs been so frustrating for me as a mom. Our reality has never aligned with the narrative about kamagra online without prescription the drug,â said Pam Andrews of Austin, Tex., who has two daughters suffering from NPC.âÂÂBut I donâÂÂt know if the company has the experience to work with the FDA to get them what they say they need. IâÂÂm scared for the kids. ThereâÂÂs zero room for error and thereâÂÂs still so much kamagra online without prescription uncertainty. It seems like a big mess.âÂÂ. |
 |
Kamagra online without prescription2010.02.05 Links added 2010.02.05 Typo3 upgraded to 4.31 2010.02.01 FE added 2010.01.25 Typo3 upgraded to 4.3 Kamagra online without prescription En rigtig god text om hvem I er som fortæller både brugerne og søgemaskinerne hvad der tilbdes.
Suspendisse aliquam, nibh a dapibus adipiscing, orci risus volutpat tortor, ut rhoncus arcu turpis ac nisl.Nulla imperdiet arcu quis libero. Ut ac pede. Curabitur fermentum tellus vel quam. In eget felis at est posuere aliquam. Donec ante. Pellentesque fermentum. Aliquam lectus ligula, euismod nec, congue nec, cursus non, quam. Donec nec risus. Suspendisse potenti. In volutpat mi nec mi. Donec eget risus. Nam tempus vehicula lorem. Proin et quam fringilla tellus fermentum dictum.Cras eu ipsum. Fusce faucibus, risus ut vestibulum semper, ante urna imperdiet eros, vel porta justo massa vitae purus. Sed aliquam hendrerit dui. Suspendisse dapibus augue at felis. Morbi velit pede, consectetuer sed, volutpat sed, ultricies in, mi. Aliquam ornare vestibulum ante. Praesent vel augue vel orci ullamcorper posuere.
Morbi ac felis et pede dictum viverra. Integer aliquam vestibulum mi. Aenean orci. Sed a lacus. Donec dui. Mauris consectetuer mauris at felis. Proin fermentum laoreet arcu. In hac habitasse platea dictumst. Nulla a mi nec quam elementum tempus. |
|
Kamagra online without prescriptionKamagra online without prescriptionKamagra online without prescription |